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ABSTRACT
NATHAN MONTGOMERY:  Epigenetic Defects in Stem Cells Deficient in Polycomb
Group Function
(Under the direction of Terry Magnuson, Ph.D.)
 During development, the expression states of many genes must be maintained
through cell divisions in order to ensure lineage-, time-, and dose-appropriate patterns of
gene expression.  This transcriptional memory is independent of permanent DNA
sequences changes and instead involves reversible epigenetic mechanisms.  Polycomb
Group (PcG) proteins represent a conserved family of developmental regulators that
mediate heritable transcriptional silencing by covalently modifying histone proteins.
Here, we demonstrate that mutations in the PcG gene Embryonic ectoderm development
(Eed) produce a variety of epigenetic defects in mouse embryos and stem cells.  EED is a
noncatalytic subunit of Polycomb Repressive Complex 2, a 600 kDa complex containing
a number of proteins, including the histone H3-lysine 27 (H3K27) methyltransferase
EZH2.  Consistent with the role of PcG genes in transcriptional memory, Eed mutant
embryos and trophoblast stem cells have defects in genomic imprinting, a process by
which an allele’s expression is dependent upon the gender of the parent from which it
was inherited.  To determine whether these gene expression defects revealed a required
role for EED in PRC2 function, we characterized the status of H3K27 methylation in Eed
mutant stem cells.  H3K7 can be mono-, di-, or trimethylated (H3K27me1, H3K27me2,
H3K27me3, respectively), but it has been unclear which of these marks are mediated by
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PRC2.  Here, we demonstrate that EED is required for all three methylation states.
Additionally, although EED is present as four distinct isoforms in mammalian cells, these
isoforms are not necessary for H3K27 methylation.  Instead, EED’s core WD-40 motifs
and histone binding domain alone are sufficient to mediate histone methylation.  Finally,
although the histone methylation defects in Eed mutant stem cells appear to be global, the
imprinted expression defects are restricted to DNA hypomethylated, extraembryonic
tissues  and to genes that are imprinted normally in DNA methyltransferase 1 (Dnmt1)
mutant placentas.  Together, these results suggest that histone methylation and DNA
methylation may have non-overlapping roles in imprinted gene regulation.
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PREFACE
The trajectory of scientific understanding is often defined by landmark
achievements punctuating periods of far more incremental progress.  I have been
fortunate to be a graduate student in genetics at an extraordinary time in the field’s
history, in the immediate aftermath of biology’s greatest achievement since cracking
life’s triplet code.  The first working drafts of the human genome were published the
same month that I interviewed for admission to the Curriculum in Genetics and
Molecular Biology at UNC.  These genetic blueprints to life have revolutionized modern
biology, and I have been fortunate to have had a front row view of the advances that have
followed their publication.
Ironically, during the same era when the amount of curated genomic sequence in
public databases was increasing logarithmically, a parallel movement had begun to
unravel the molecular mysteries underlying non-DNA based mechanisms of heredity, a
field known as epigenetics.  Eighteen months before I started my graduate training, Dr.
Brian Strahl, who was then a postdoctoral researcher at the University of Virginia but
who would later become a member of my thesis committee, published a landmark paper
with Dr. David Allis, in which they proposed that covalent modifications on the histone
proteins that package our DNA function as a heritable, regulatory code, instructing cells
how to respond to the associated genes.  Seven months later and less than a year before I
arrived at UNC, the molecular players responsible for this code began to be identified
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when Dr. Thomas Jenuwein and his colleagues in Vienna reported the identification of
the first enzyme, SUV39H1, capable of adding methyl groups to histone tails.
Hence, I started my graduate studies at an exciting time, and already, I had a
considerable interest in histone biology.  As an undergraduate, I had studied the yeast
Chromatin Assembly Factor-I (CAF-I), which is responsible for loading histones onto
DNA to produce nucleosomes.  Excited by Jenuwein’s results as well as a flurry of
papers that followed, it was a relatively easy decision to focus my graduate studies on
epigenetics.  It was clearly a field poised to make important progress on fundamental
biological questions.
Whereas my decision to study epigenetics was largely a conscious calculation
about the future, my decision to focus specifically on the mouse Polycomb Group gene
Eed was probably more a consequence of its past.  Perhaps no regulator of epigenetic
phenomena in the mouse has a richer history than Eed.  The gene was first uncovered by
Drs. Bill and Lee Russell, who identified deletions encompassing Eed as part of specific
locus testing at Oak Ridge National Laboratory.  Later, Dr. Eugene Rinchik generated
point mutations that failed to complement those deletions, and in 1996, a postdoctoral
researcher in the Magnuson laboratory, Dr. Armin Schumacher, positionally cloned the
gene.  In between, work by Dr. Salome Waelsch and by Dr. Cindy Faust, another
postdoctoral researcher in the Magnuson laboratory, began to reveal the fascinating
biology uncovered by these mutations.  In short, Eed is a rare mouse gene in that it was
identified by classical genetic approaches more commonly employed in Drosophila
laboratories.  That history appealed greatly to me, and I was more than a little enamored
by the opportunity to be linked, albeit indirectly by a thesis project, to great geneticists.
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Given that background, it is more than a little ironic then that the work that
follows is more molecular biology than genetics.  Throughout my graduate career, I have
tried to go where the science has taken me, even when it has taken me places I did not
initially expect to go.  After demonstrating with Jesse Mager that Eed is required for the
imprinted expression of a number of genes in the mouse (Chapter 2), I decided that
fundamental, mechanistic questions remained unanswered. Those questions required the
tools of molecular biology rather than the tools of genetics.  The pages that follow are my
attempts to answer those questions.
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CHAPTER 1
BACKGROUND AND INTRODUCTION
21.1  EPIGENETIC INHERITANCE AND THE HISTONE CODE
During development, gene expression states established in progenitor cells are
often maintained through cellular divisions in descendant cell populations[1].  This
“transcriptional memory” insures lineage-, time-, and dose-appropriate patterns of gene
expression.  In recent years, considerable effort has been focused towards elucidating the
molecular mechanisms underlying transcriptional memory.  Of particular importance, the
ability to derive viable clones from terminally differentiated somatic cells and the ability
of some differentiated cell types to transdifferentiate demonstrate that transcriptional
memory is independent of permanent DNA sequence changes and instead involves
reversible, non-genetic phenomena[2-4].  Collectively, these DNA sequence independent
mechanisms of cellular heredity are known as epigenetics.
Units of epigenetic inheritance are expected to share at least two critical features
with DNA, the unit of genetic inheritance.  First, they must harbor information, and
second, they must be able to be propagated.  Distinguishing them from DNA, units of
epigenetic inheritance must also be reversible, as epigenetic states are often reset during
germline or preimplantation development and after somatic cell nuclear transfer[5].  In
recent decades, the molecular mechanisms underlying epigenetic inheritance have begun
to be revealed.  From this work, it is now clear that two prominent mechanisms of
epigenetic regulation are DNA methylation and covalent histone modifications[6].  These
mechanisms appear to fulfill the criteria expected of units of epigenetic inheritance.
In many species, the cytosines of CpG dinucleotides are often symmetrically
methylated.  Methylated cytosines control gene expression states, are propagated by
maintenance DNA methyltransferases, and can be reversed by both passive and active
3means[6].  Consequently, DNA methylation fulfills the criteria expected for a unit of
epigenetic inheritance.  However, although DNA methylation is clearly an important
epigenetic mark in both plants and mammals, it is unlikely to be the sole unit of
epigenetic inheritance.  In other species, including the fruit fly Drosophila melanogaster
and the nematode Caenorhabditis elegans, little if any DNA methylation is present[7, 8].
Moreover, even in mammals, DNA methylation is not universally required for epigenetic
phenomena[9-11].  As a result, alternative mechanisms must also be crucial for
epigenetic inheritance.
Histones are small, basic, evolutionarily conserved proteins that associate with
eukaryotic DNA to produce DNA-protein complexes called nucleosomes[12].  Each
nucleosome consists of an octamer of histone proteins (two each of histones H2A, H2B,
H3, and H4) around which approximately 147 bp of DNA is wrapped[13]. Histones have
long been appreciated to perform an important function in packaging massive eukaryotic
genomes into relatively small eukaryotic nuclei, but more recently, it has become clear
that histones also perform important regulatory roles[12].
Diverse types of chemical modifications are found on histone amino-terminal
tails, including acetylation, methylation, phosphorylation, poly-ADP ribosylation,
sumoylation, and ubiquitination[14].  Recently, combinations of such modifications have
been proposed to function as a “histone code” that controls epigenetic states[14, 15].  In
this model, histone modifying enzymes, such as histone acetyltransferases and histone
methyltransferases (HMTases), write a code that instructs cellular machinery how to
respond to the associated DNA.  Subsequently, this code is recognized by other proteins,
which bind histone tails harboring a specific modification or combination of
4modifications, much in the same way that sequence-specific transcription factors bind
DNA sequences.  These recognition proteins then execute the code originally written by
the histone modifying enzymes.
 Early support for the histone code came from work with Su(Var) 3-9 Homolog 1
(SUV39H1), Heterochromatin Protein 1 (HP1) and their homologs in yeast and
Drosophila.  Jenuwein and colleagues demonstrated that SUV39H1 is a HMTase with
enzymatic activity directed towards histone H3 at lysine 9 (H3K9)[16].  This catalytic
activity resides in an evolutionary conserved domain called the SET domain, which is
found in many lysine methyltransferases[17].  Consistent with the histone code
hypothesis, after SUV39H1 methylates H3K9, HP1 binds to the modified histone via its
chromodomain and promotes higher order chromatin structures that inhibit
transcription[18].  In the last decade, the number of enzymes demonstrated to covalently
modify histones and the number of proteins shown to bind specifically to modified
histones have grown dramatically[19].
In addition to harboring regulatory information, covalent histone modifications
appear capable of fulfilling the remaining requirements for a heritable unit of epigenetic
inheritance, at least in some cases.  First, at least some histone modifications may be
propogated through mitotic divisions.  Histones H3 and H4 exist as a heterotetramer in
intact nucleosmes, and historically, that tetramer was thought to remain intact during
DNA replication[20].  This suggests that, unlike DNA replication, histone deposition may
not be a semiconservative process, meaning that one sister chromatid may inherit the
parental H3/H4 tetramer with appropriate modifications while the other sister chromatid
inherits a nascent tetramer lacking those modifications[21].  By itself, this mode of
5histone replication appears to be incompatible with histone modifications functioning as a
unit of epigenetic inheritance.  However, at least in the case of H3K9 methylation, the
mark is still propogated.  HP1, via its chromoshadow domain, can recruit SUV39H1 to
methylate adjacent nucleosomes, potentially propagating H3K9 methylation to nascent
histones after replication, provided that multiple, adjacent nucleosomes harbored the
modification prior to replication and provided that modified parental tetramers are
transmitted to each sister chromatid (Figure 1.1)[22].  Such a mechanism would allow
histone modifications to function as primary epigenetic marks, even if H3/H4 tetramers
are not inherited semiconservatively.  Interestingly, however, more recent data is
challenging traditional views of H3/H4 deposition. These studies demonstrate that
histone H3 and H4 associated with chromatin assembly complexes exist as dimers, rather
than as tetramers, arguing that H3/H4 tetramers may actually separate during DNA
replication[23].  If true, histone deposition may be truly semiconservative, and all histone
modifications may be faithfully propogated through cell divisions (Figure 1.2).  In either
case, the competing models both provide compelling mechanisms by which histone
modifications may be self-propagating, as required for any primary epigenetic mark.
Finally, fulfilling the last requirement for any unit of epigenetic inheritance, covalent
histone modifications are typically reversible.  For instance, histone deacetylases and
histone demethylases remove acetyl groups and methyl groups, respectively, from
histones, and in some cases, patterns of histone modifications are erased completely by
histone replacement[24-27].
The complexity of the histone code is a consequence not only of the large number
of modified residues and the diverse types of chemical modifications found on histones,
6but also it is a product of the number of moieties added to a particular residue.  For
instance, lysines can be mono-, di-, or trimethylated, and potentially, these three methyl
states could mediate three distinct biological outcomes[28].  Consistent with this
expectation, the chromodomain of HP1 binds trimethylated H3K9 with a binding affinity
seven- and ten-fold greater than its affinity for dimethylated and monomethylated H3K9,
respectively[29].  Additional support for functional distinctions between lysine methyl
states comes from localization data.  HP1α colocalizes only with the trimethylated form
of H3K9 at pericentric heterochromatin in vivo[18, 28].  Additionally, histone H4
trimethylated at lysine 20 is a marker of the pericentric heterochromatin, whereas the
monomethylated form of that residue is instead a marker of the inactive X
chromosome[30, 31].  Even without knowing the precise functions of all of these marks,
these results demonstrate that the number of methyl groups added to a particular
nucleosome is a regulated process.
1.2.  POLYCOMB GROUP BACKGROUND
One prediction of the histone code hypothesis is that proteins that mediate and
recognize histone modifications will have important roles in development.  Polycomb
Group (PcG) proteins represent one conserved family of developmental regulators that
mediate heritable transcriptional silencing by modifying histones[32, 33].  Bona fide PcG
genes produce a specific class of developmental defects when mutated in Drosophila[7,
8].  The fly thorax normally consists of three segments, known as T1, T2, and T3.  In
male flies, the legs of the first thoracic segment, T1, are distinguishable by the presence
of characteristic mating structures called sex combs.  Mutations in PcG genes transform
7the identity of one or more thoracic segments, producing flies with T1-T1-T1 or T1-T1-
T3 patterning defects instead of the typical T1-T2-T3 thorax.  Accordingly, male PcG
mutants have inappropriate sex combs on the legs of their second and even third thoracic
segments, which explains the nomenclature of PcG genes, including Polycomb, extra sex
combs, and Sex combs on the midleg.
The patterning defects in PcG mutant flies are a consequence of misexpression of
homeotic genes in the Antennapedia and bithorax complexes[7, 8, 34].  During early
Drosophila development, homeotic gene expression patterns are established by gap and
pair-rule segmentation proteins, which are DNA sequence specific transcription factors.
However, expression of gap and pair-rule proteins ceases by mid-embryogenesis.
Subsequently, the patterns established by those initiating molecules are maintained by the
combined action of PcG proteins, which are required to keep repressed homeotic genes
silent in descendant cells, and trithorax group proteins, which are required to keep
expressed homeotic genes active in descendant cells.  The molecular mechanisms linking
gap- and pair rule-mediated initiation to PcG- and trithorax group-mediated maintenance
remain elusive.
Homologs of fly PcG genes have been identified in many other species, including
plants, nematodes, and mammals, and in each case, the homologous genes appear to play
crucial roles in mediating heritable transcriptional silencing[7, 33, 35].  In the mouse,
Mus musculus, mutations in PcG genes produce patterning defects conceptually similar to
the homeotic transformations observed in Drosophila.  As in fly, these phenotypes
involve misexpression of homeotic genes, often resulting in transformation of various
vertebrae to the identity of their anterior or posterior neighbors[36].
81.3.  BIOCHEMICAL CHARACTERIZATION OF PcG COMPLEXES
Biochemical characterization of PcG complexes has provided considerable insight
into the molecular mechanisms underlying PcG-mediated silencing.  In both flies and
mammals, PcG proteins exist in two biochemically separable complexes, generally
known as Polycomb Repressive Complex 1 (PRC1) and Polycomb Repressive Complex
2 (PRC2).  Because a number of fly PRC1 genes are duplicated in the mammalian
lineage, in the mouse, PRC1 refers to a heterogeneous collection of 2 MDa complexes,
which have not been fully characterized[32].  Critical subunits of PRC1 include
chromodomain containing proteins (Cbx2, Cbx4, Cbx6, Cbx7, or Cbx8 in mouse and Pc
in fly) and ubiquitin E3 ligases (Ring1a or Ring1b in mouse and Sex combs extra in
fly)[37].  The latter allows PRC1 to monoubiquitinate histone H2A at lysine 119[38].
While this mark appears essential for PcG-mediated silencing, it is not clear how the
presence of monoubiquitin on histone H2A interferes with transcription.
PRC2 is an approximately 600 kDa complex defined in the mouse by the presence
of the SET-domain containing histone methyltransferase EZH2 (fly E(Z)), the WD-repeat
protein EED (fly ESC), the Zn-finger protein SUZ12 (fly Su(Z)12), and additional
proteins, including histone deacetylases, which appear to be at least transiently associated
with the complex[39-41].   EZH2 and its homologs in fly and nematode have all been
shown to methylate histone H3 at lysine 27 (H3K27)[40-44].  However, the functions of
the other, noncatalytic subunits are less clear.  In vitro EZH2 lacks HMTase activity in
the absence of EED and SUZ12, indicating that these subunits have some undefined role
in EZH2-mediated histone methylation[45].  Additionally, the N-terminus of both EED
9and ESC appear to bind histones, and fly Su(Z)12 may be necessary for PRC2 association
with chromatin[46, 47].
In mammals, the composition of PRC2 is complicated by the presence of four
distinct isoforms of the noncatalytic subunit EED[48, 49].  These isoforms are thought to
be produced by utilizing four, in-frame translational start sites in a common Eed mRNA.
Although most eukaryotic proteins initiate translation at canonical methionine-encoding
AUG codons, an increasing number of proteins are known to initiate translation at non-
AUG codons.  Often, these noncanonical initiation sites produce upstream isoforms of
proteins also translated from downstream AUG codons, and generally, the noncanonical
start codons differ from the canonical AUG sequence at only one nucleotide position[50,
51].  The putative EED isoform start sites are proposed to conform with both of these
general trends;  EED-1 and EED-2 are thought to be translated from non-canonical,
upstream GUG codons at nucleotide positions 169-171 and 274-276 in the Eed mRNA,
and EED-3 and EED-4 are believed to be translated from downstream, AUG codons at
positions 454-456 and 496-498, respectively (Figure1.3)[48, 52].  However, these sites
were proposed on the basis of limited, in vitro studies utilizing a rabbit reticulocyte, cell-
free translation system[52].  At the outset of this work, EED translational start sites had
not been characterized in living cells.
The functions of the four EED isoforms remain unclear, although isoform usage
appears to be developmentally regulated.  In particular, EED-2 has been reported to be
expressed only in undifferentiated stem cells and in tumor tissue, suggesting a potential
role for this isoform in pluripotency[49].  Mechanistically, initial in vitro studies
suggested that EED isoforms may control the substrate specificity of EZH2.  Specifically,
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EED-1 and EED-2 were suggested to direct EZH2 activity towards histone H1 at lysine
26, while EED-3 and EED-4 were reported to direct EZH2 activity towards the
conventional H3K27 substrate[48].  However, subsequent in vitro studies failed to
confirm these results, and to date, the only target of EZH2 or its homologs that has been
confirmed in vivo is H3K27[53].
H3K27 can be mono-, di-, or trimethylated (H3K27me1, H3K27me2, and
H3K27me3, respectively)[28].  While the functions of the former two marks remain
unclear, H3K27me3 alone appears to function as a binding platform for PRC1
chromodomain containing proteins, in much the same way that trimethylated H3K9
recruits HP1 binding[29, 54].  Support for this conclusion comes from both in vitro and
in vivo work.  In vitro, the binding affinity of fly Pc for H3K27me3 is four- to five-fold
greater than its affinity for H3K27me1 or H3K27me2[29].  In vivo, Pc and H3K27me3
staining largely colocalize on fly polytene chromosomes, but Pc and H3K27me2 do
not[55].  Additionally, Pc can be competed away from chromatin by trimethylated
H3K27 peptides but not by dimethylated H3K27 peptides[55].  Hence, considerable
evidence implicates H3K27me3 in recruiting PRC1.  However, the relationship between
PRC1 and H3K27me3 appears to be more complicated than the relationship between HP1
and H3K9me3.  Even where PRC1 and H3K27me3 colocalize cytologically, that
colocalization is limited to only a subset of H3K27 trimethylated nucleosomes[56].
Finally, at the outset of this work, it was unclear whether PRC2 alone was capable of
mediating mediating H3K27 methylation, or whether other complexes could mediate or
were even required for one or more of the H3K27 methylation states.
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Despite extensive characterization of PcG complexes, it remains unclear how PcG
proteins and PcG-mediated histone modifications inhibit transcription. It is generally
assumed that PcG proteins condense local chromatin environments to block access to the
transcriptional machinery, and in fact, preincubating nucleosomal arrays with PRC1
blocks SWI/SNF-mediated chromatin remodeling and transcription in vitro, suggesting
that the downstream-acting PcG complex mediates a chromatin state that is refractory to
transcription[37, 57].  More recently, reconstituted PRC1 complexes were shown to
physically compact a chromatinized template[58].  However, because PRC1 proteins
were present at extremely high concentrations in all of those experiments, it remains
unclear whether PcG proteins are able to condense chromatin under physiological
conditions, and no existing data in living cells confirms this conclusion[32].  In fact,
chromatin immunoprecipitation experiments demonstrate that RNA polymerase II
localizes to PcG-silenced promoters, implying that PcG-mediated repression is not
simply a consequence of promoter inaccessibility[59].  As an alternative to local
chromatin condensation, PcG proteins could interfere with cellular machinery required
for transcription.  Fly PRC1 copurifies with TBP-associated factors (TAFs), suggesting
that PcG proteins might inhibit transcription by directly associating with components of
the generation transcription machinery[60].  However, similar interactions have not been
observed in mammalian cells[32].  Finally, PcG-mediated histone modifications could
directly impact transcription.  Although PRC2-mediated H3K27me3 may function
primarily to recruit PRC1, the function of PRC1-mediated H2A ubiquitination is unclear.
It is possible that this downstream mark interferes directly with transcription by some
unknown mechanism.
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Whatever mechanism explains PcG-mediated silencing, it is unlikely to involve a
spreading mechanism comparable to position effect variegation in the fly or SIR-
mediated silencing in yeast.  In flies, PcG proteins are recruited by sequence-specific
DNA binding proteins to Polycomb Response Elements (PREs)[61].  Similar elements
have not been identified in mammals, where little is known about targeted recruitment of
PcG proteins.  Although a single insulator placed between a PRE and a promoter blocks
PcG-mediated silencing, this block is bypassed when an even number of insulators
separates the PRE and the promoter, implying that PcG proteins do not track along the
DNA from their recruitment site to their target[62].
1.4.  CHARACTERIZATION OF EED FUNCTION IN VIVO
The in vivo functions of mammalian PRC2 have been revealed largely by work
with mice and mouse embryos harboring mutations in Eed, Ezh2, and Suz12.  Of these,
an allelic series of mutations in Eed has been particularly revealing.  Deletions
encompassing Eed were first generated by William and Lee Russell at Oak Ridge
National Laboratory, as part of specific locus tests designed to characterize the dangers of
ionizing radiation in mammals[63, 64].  Eed is tightly linked to Tyrosinase (Tyr), a
mouse coat color gene used as a visible marker in the Russells’ specific locus test, and
lesions removing Tyr frequently deleted Eed as well.  Mapping deletion breakpoints
around Tyr identified six regions required for mouse viability, including one region that
caused lethality at embryonic day 8.5 (E8.5) when deleted[63, 65, 66].  Subsequently,
using the chemical mutagen N-ethyl-N-nitrosurea (ENU), point mutations were generated
that failed to complement this deletion phenotype[67, 68].  Mice harboring these point
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mutations were then used to positionally clone the gene responsible for the E8.5 lethality
in the deletion mutants.  That gene, now known as Embryonic ectoderm development
(Eed), is a five-WD repeat protein homologous to the fly PcG gene esc[69].
The phenotypic consequences of two ENU-generated Eed point mutations have
been characterized extensively. Eedl7Rn5-3354SB is a leucine-to-proline substitution in the
third of EED’s five confirmed WD-40 motifs (Figure 1.3)[69]. Eedl7Rn5-3354SB homozygous
embryos appear to recapitulate the phenotype caused by Eed deletion mutations,
suggesting that the Eedl7Rn5-3354SB is a null allele (as a result, Eedl7Rn5-3354SB will subsequently
be referred to as Eednull or Eed-)[70].  Supporting the possibility that EED is absolutely
required for PRC2 function, Eednull/null embryos arrest at perigastrulation stages
comparable to the stages at which Ezh2 and Suz12 mutant embryos also arrest[71, 72].
Consistent with Eed’s classification as a mouse PcG gene, animals homozygous
for a second, hypomorphic Eed allele, Eedl7Rn5-1989SB (herein referred to as Eedhypo) exhibit
segmental patterning defects reminiscent of the homeotic transformations observed in esc
mutant embryos[69, 73]. In this mutation, a nonpolar isoleucine is converted to a polar
asparagine in the same WD-40 motif in which the substitution caused by the Eednull allele
resides (Figure 1.3)[69].  On outbred backgrounds, Eedhypo/hypo animals are generally
viable but runted.[68, 69]  As with fly PcG mutant patterning defects, the homeotic
transformations associated with the hypomorphic allele are a consequence of shifted
homeotic gene expression boundaries[73, 74].  Eedhypo/null compound heterozygotes exhibit
an intermediate phenotype, with homeotic expression defects identical to Eedhypo/hypo
animals and with midgestation lethality, due to the absence of secondary trophoblast
giant cells.
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In addition to regulating anterior-posterior patterning, mouse PcG genes also
appear to play important roles in epigenetic regulation of additional targets, most notably
the inactive X chromosome (Xi).  In mammals, XX female mammals achieve dosage
compensation by inactivating one of their two X chromosomes.  In mouse
extraembryonic tissues as well as in preimplantation mouse embryos, the paternal X
chromosome is preferentially, if not universally, silenced[75].  As a consequence, X-
chromosome inactivation in mouse extraembryonic tissues is “imprinted”, meaning that
one of the two X-chromosomes must inherit an epigenetic mark dictating either that the
paternal X-chromosome be silenced or that that maternal X-chromosome remain active.
Mutations in the mouse PcG gene Eed lead to aberrant reactivation of the normally silent
paternal X chromosome in a subset of extraembryonic cells, indicating that PcG proteins
are required for the maintenance of imprinted X-chromosome inactivation[74, 76].
Additionally, PcG proteins colocalize with the Xi, as do H3K27me3 and ubiquitinated
histone H2A, histone modifications associated with PcG activity[77-79].
In mammals, a number of autosomal genes are also imprinted, and the
demonstration that Eed is required for imprinted X-chromosome inactivation led to an
examination of Eed’s role in the regulation of autosomal imprinted genes.  That work is
presented in Chapter 2.  Chapters 3 and 4 detail mechanistic studies addressing the
molecular details of EED function.  In chapter 3, work is presented characterizing EED’s
role in H3K27 methylation.  In chapter 4, that work is extended by mapping regions of
the EED protein required to mediate H3K27 methylation.
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FIGURE 1.1.  Model for the propagation of histone marks from intact parental
H3H4 tetramers
(Top Panel)  A series of nucleosomes with methylated H3K9 (red triangle), a mark bound
specifically by HP1.  For simplicity, only histones H3 and H4 are shown.
(Middle Panel)  After replication, modified, parental tetramers are inherited intact.
Modified, parental tetramers and unmodified, nascent tetramers are distributed to both
sister chromatids.  HP1's chromoshadow domain binds SUV39H1, recruiting that H3K9
HMTase to methylate the unmodified, nascent tetramers.  For simplicity, spreading of
H3K9 methylation is shown unidirectionally.
(Bottom Panel)  After SUV39H1 propagates the mark, both sister chromatids harbor the
parental chromatin profile, allowing the epigenetic state to be inherited by both daughter
cells after cell division.
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FIGURE 1.2.  Model for the propagation of histone marks from disassembled H3H4
tetramers
(Top Panel)  A series of nucleosomes with methylated H3K9 (red triangle), a mark bound
specifically by HP1.  For simplicity, only histones H3 and H4 are shown.
(Second Panel)  During replication, parental H3/H4 tetramers are disassembled to form
H3/H4 dimers, which mix with nascent, unmodified H3/H4 dimers to generate tetramers
containing both parental, modified histones and nascent, unmodified histones.
(Third panel)  Hybrid nucleosomes retain the parental modification on one H3 in each
tetramer.  This mark is propagated to the nascent histones in the same or neighboring
nucleosomes by SUV39H1 which is recruited by its association with HP1's
chromodomain. For simplicity, spreading of H3K9 methylation is shown unidirectionally.
(Bottom Panel)  After SUV39H1 propagates the mark, both sister chromatids harbor the
parental chromatin profile, allowing the epigenetic state to be inherited by both daughter
cells after cell division.
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FIGURE 1.3. Putative EED translation start sites and WD-40 motifs
EED isoform translation start sites proposed on the basis of in vitro translation studies are
indicated as EED-1, -2, -3, and -4, respectively  [52].  These numbers refer to EED start
sites proposed by Denisenko and Bomsztyk to reside at mRNA positions GUG 169-171,
GUG 274-276, AUG 454-456, and AUG 496-498.  Diagonally-hatched boxes refer to
EED-40 motifs at sequences 721-808 (WD-40 motif 1), 1012-1105 (WD-40 motif 2),
1150-1240 (WD-40 motif 3), 1330-1444 (WD-40 motif 4), and 1672-1762 (WD-40 motif
5). (Figure not drawn to scale)
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CHAPTER 2
IMPRINTING DEFECTS IN EED MUTANT EMBRYOS AND CELLS
29
A portion of the work in this chapter was published in Nature Genetics 33(4):  502-507.
2.1.  INTRODUCTION
In mammals, maternally-inherited and paternally-inherited genomes are
functionally nonequivalent due to the presence of at least 80 imprinted autosomal genes
and the imprinted X-chromosome [1].  Unlike most genes, imprinted genes are
monoallelically expressed in a parent-of-origin dependent manner, and as a consequence,
both parental genomes are required for normal mammalian development and physiology
[2-4].
Most imprinted genes reside in clusters that are co-regulated by imprinting control
regions (ICR) [5].  These ICRs harbor germline imprints controlling the expression of
nearby imprinted genes and are often identifiable by distinct germline DNA methylation
patterns in eggs and in sperm.  Imprinting defects in various DNA methyltransferase
mutant mice demonstrate that these and other, post-zygotic differentially methylated
regions (DMRs) are important for imprinted gene expression [6-10].  However, the
mechanisms controlling imprinted gene expression are poorly understood and may differ
between clusters.
One of the most striking examples of imprinting in mammals is imprinted X-
chromosome inactivation.  Female mammals achieve dosage compensation by
inactivating one of their two X-chromosomes [11].  In marsupials and monotremes and
also in mouse preimplantation embryos and extraembryonic tissues, X-chromosome
inactivation is imprinted, and the paternally inherited X-chromosome is preferentially
inactivated [12].  Studies on the inactive X-chromosome (Xi) have been particularly
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revealing in the effort to elucidate molecular mechanisms underlying transcriptional
silencing in general and imprinting in particular, because the size of the Xi allows
proteins enriched on that chromosome to be identified cytologically.  These studies
suggest that transcriptional silencers identified in other systems are frequently enriched
on the inactive X-chromosome.  For instance, PcG proteins and PcG-mediated histone
modifications are both found on the Xi, and the PcG gene Eed is required to maintain
imprinted X-chromosome inactivation in a subset of mouse extraembryonic cells and in
differentiating trophoblast stem cells, confirming that PcG-mediated silencing is
functionally necessary for imprinted X-chromosome inactivation in those cells [13-17].
Less is known about the molecular mechanisms controlling regulation of
autosomal imprinted genes.  The imprinted genes on distal mouse chromosome 7
represent one of the best studied examples of autosomal imprinted genes in the mouse.
At least fifteen imprinted genes are found in a 1.2 Mb region of this chromosome.  These
15 genes are part of two separable imprinting clusters, which employ distinct regulatory
mechanisms and are defined by distinct germline ICRs [5].  Imprinting of the more
proximal H19/Igf2 cluster appears to be regulated by DNA-methylation sensitive and
allele-specific binding of the insulator CTCF, which blocks of the association of several
genes with an upstream enhancer on the maternal but not on the paternal chromosome
[18, 19].
Imprinting at the more distal KvDMR cluster appears to be more complicated.
The KvDMR cluster contains ten maternally expressed genes and one paternally
expressed gene spread over 800 kb (Figure 2.1).  The most proximal of these genes,
Ascl2, sits less than 300 kb from Ins2, the most distal gene in the H19/Igf2 cluster, but
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regulation of the two clusters is completely independent, with deletion of the germline
ICRs in either cluster having no impact on imprinted expression in the other cluster [20,
21].  The regulation of the KvDMR cluster appears to share a number of conceptual and
mechanistic similarities with imprinted X-chromosome inactivation.  First, although
DNA methylation plays a prominent role in imprinting at other clusters and in the random
X-chromosome inactivation that occurs in mouse embryonic tissues, neither imprinted X-
chromosome inactivation nor imprinted expression of a number of genes in the KvDMR
cluster are disrupted in DNA methyltransferase 1 (Dnmt1) mutant extraembryonic tissues
[22-24].  Additionally, both processes are dependent on cis-acting, non-coding RNAs.  Xi
specific transcript (Xist) is required in cis to silence genes on the Xi, and Kcnq1ot1
expressed from the paternal allele is similarly required to silence the neighboring,
paternal alleles of the protein-coding genes in the KvDMR cluster [21, 25, 26].  Given the
requirement for Eed in imprinted X-chromosome inactivation and given the similarities
between the Xi and the KvDMR cluster, we hypothesized that PRC2 might also be
required for imprinting at this autosomal locus.
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2.2. METHODS AND MATERIALS
Cell lines and cultures
CD1.JF1 (F1) hybrid trophoblast stem (TS) cells lines 5-4 (Eed+/null) and 3-5
(Eednull/null) were grown on irradiated fibroblast feeders as previously described [27, 28].
To differentiate, these cells were removed from Fgf4 and Activin.  Before harvesting for
expression analyses, cells were passaged at least twice in the absence of feeders to avoid
contamination.
Expression analyses
RNA was isolated from wild-type or Eednull/null E7.5 embryos, wild-type or
Eedhypo/null E9.5 embryos, and wild-type or Eednull/null TS cells using TRIzol Reagent
(Invitrogen). RNA was extracted from the TRIzol lysate in phenol-chloroform and
precipitated with an equal volume of isopropanol.  Precipitated nucleic acids were
washed in 70% ethanol and resuspended in sterile water.  In order to eliminate
contaminating genomic DNA, RNA preparations were incubated for one hour at 37º C
with DNase (Ambion).
cDNA was prepared using SuperScriptII Reverse Transcriptase (Invitrogen) and
then subjected to RT-PCR.  Whenever possible, intron-spanning amplicons were utilized
to avoid DNA contamination.  After RT-PCR, single nucleotide polymorphisms were
discriminated by sequencing or restriction digest as indicated below.  Insertion/deletion
polymorphisms were discriminated by single strand conformation polymorphism (SSCP)
analysis or by non-denaturing high performance liquid chromatography (HPLC).  For
SSCP analysis, RT-PCR reactions were spiked with 32P-dCTP and denatured by boiling
in formamide.  Then, reactions were loaded onto acrylamide gels (0.5X MDE, 0.6X TBE,
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0.04% TEMED, 0.04% APS) and run overnight.  For HPLC analysis of indels, PCR
reactions are run over an affinity column and then eluted with increasing concentrations
of acetonitrile.
Primers and assays utilized for these experiments are show below.
Ascl2
Fwd: TTTCCAGTTGGTTAGGGGGC
Rev: GGGACAGAGGTCATCTTTATTGTGC
Eednull/null Embryo Assay:  Direct sequencing
CD1:  A at position 86 beginning with the 5’ end of the reverse primer
JF1:  G at position 86 beginning with the 5’ end of the reverse primer
Eedhypo/null Embryo and Eednull/null TS Cell Assay:  Direct sequencing
CD1:  T at position 290 beginning with the 5’ end of the forward primer
JF1:  C at position 290 beginning with the 5’ end of the forward primer
Cdkn1c
Fwd:  CAGAACCGCTGGGACTTCAAC
Rev:  TGGGCTGCTCTACGCAACC
Assay:  Tsp509I digest
CD1:  680, 323 bp products
JF1:  1003 bp product
Cd81 (Tapa1)
Fwd:  GATCCCTGGAGTGACCAGAG
Rev:  CCCATGTGTGATGTCAGCTC
Assay:  Nondenaturing High Performance Liquid Chromatography
CD1:  183 bp product
JF1:  188 bp product
Kcnq1 (Kvlqt1)
Fwd:  GATCACCACCCTGTACATTGG
Rev:  CCAGGACTCATCCCATTATCC
Embryo Assay:  Direction sequencing digest
CD1:  T at position 325 beginning with the 5’ end of the forward primer
JF1:  G at position 325 beginning with the 5’ end of the forward primer
TS Cell Assay:  AluI digest
CD1:  215, 164, 108, 29 bp products
JF1:  379, 108, 29 bp products
Kcnq1ot1 (Lit1)
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Fwd:  GCTCCATCTTCGTTTTGCCG
Rev:  ACTCCACTCACTACCTTGGTGCTG
Assay:  HpyCH4IV digest
CD1:  228, 118 bp products
JF1:  346 bp product
Msuit
Fwd: AGCTGCTGAGAGGACTGACTGAAC
Rev: GGAGAAAGCAAGTGATGCAAGC
Assay:  Direct sequencing
CD1:  G at position 104 beginning with the 5’ end of the forward primer
JF1:  C at position 104 beginning with the 5’ end of the forward primer
Tssc3 (Ipl/Phlda2)
Fwd: CTGGAGAAGCGAAGCGACAG
Rev: CAACTGGTCCCGTGCGTTTC
Embryo Assay:  Direct sequencing
CD1:  T at position 352 beginning with the 5’ end of the reverse primer
JF1:  G at position 352 beginning with the 5’ end of the reverse primer
TS Cell Assay:  Direct sequencing
CD1:  A at position 33 beginning with the 5’ end of the forward primer
JF1:  C at position 33 beginning with the 5’ end of the forward primer
Tssc4
Fwd: ATGGCAGCAAGAAGCGGAG
Rev: CCTAAACACTGGGGCACAAAGG
Assay:  AluI digest digest
CD1:  239 bp product
JF1:  172, 66 bp products
Tssc5 (Slc22a1l/Impt1)
Fwd: TCACGCATACCCTCTGCCC
Rev: CCAGTCCCACAACAGCAAAGAC
Assay: NdeI digest
CD1:  559 bp product
JF1:  416 + 143 bp product
For all analyses of imprinted expression in embryos, CD1 animals were used as
dams, and JF1 animals were used as sires.  F1 TS cells were derived from a cross
between JF1 dams and CD1 sires.
Fluorescence in situ hybridization (FISH)
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BAC preparation
Bacterial Artificial Chromosomes (BACs) containing genomic DNA
corresponding to either the biallelically expressed gene Dlx1 (Incyte Genomics
A0199N02) or the imprinted genes Ascl2, Cd81/Tapa1, and Tssc4 (BACPAC, clone
RP24-376H20) were utilized as templates in nick translation reactions in order to
generate DNA FISH probes.  BACs were prepared using Qiagen maxiprep kits, following
the manufacturer’s protocol for plasmid DNA preparation.  However, after the addition of
Neutralization Buffer P3, lysates were centrifuged twice for fifteen minute at 9000 x g.
DNA was precipitated from the supernatant with isopropanol, washed in 70% ethanol,
and then resuspended in Qiagen Elution Buffer.  BAC identity and preparation purity
were assessed by restriction digest and comparison to BAC fingerprints predicted by
Internet Contig Explorer (iCE).
Probe labeling
dCTP-Cy3 labeled FISH probes were generated using BAC templates and an
Amersham nick translation kit, according to the manufacturers instructions and as
previously described [29].  Subsequently, smaller probe fragments were generated by
incubating labeled DNA with dilute DNase for 4 hours at 15° C.  The digestion was
terminated by treatment with 0.2 M EDTA, and double stranded probes were denatured
by incubating for 3 minutes at 95° C.  Probe fragments were separated from
unincorporated dCTP-Cy3 on a G50 sephadex column (Roche).  In order to reduce
nonspecific hybridization, unlabeled Cot-1 DNA and salmon sperm DNA were added to
block repetitive sequences in the BAC probes.  Next, the labeled and blocked probes
were precipitated with one-tenth volume of sodium acetate and three volumes of ethanol.
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Finally, precipitated DNA was washed in 70% ethanol and resuspended in hydrization
buffer (50% formamide, 10% dextran sulfate, 1X SSC).
Probe hybrdization
Wild-type and Eednull/null TS cells were grown to mid-confluency and pulse labeled
for one hour in BrdU (20 µM) to label cells in S phase.  Then, the cells were harvested,
swollen in hypotonic solution (75 mM Kcl), fixed (3:1 methanol:acetic acid), and
dropped onto poly-lysine coated slides (Poly-prep, Sigma).  DNA from dropped cells
was denatured (70% deionized formamide, 2X SSC for 2 minutes at 70° C) and then
dehydrated by a series of ethanol washes.  Slides were incubated overnight in a humid
chamber at 37° C with FISH probes diluted in hybridization buffer, and then washed, first
in 50% formamide/2X SSC and then in a 2X, 1X, 4X series of SSC washes without
formamide.
Immunofluorescence
After FISH probe hybridization, nuclei actively replicating DNA were identified
by immunofluorescence.  Briefly, slides were blocked by incubation for 30 minutes with
anti-BrdU blocking buffer (4X SSC, 4mg/mL bovine serum albumin (BSA), 0.1%
Tween).  After blocking, slides were incubated for 90 minutes with FITC-conjugated
anti-BrdU antibodies (Becton Dickinson) diluted 1:200 in blocking buffer.  Blocking and
antibody incubations were always performed at 37° C in a humid chamber.  After the
antibody incubation, slides were washed in 4X SSC, first with and then without 0.1%
Tween.  Finally, slides were mounted with Vectashield™ containing 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Vector Laboratories).  Stained slides were
visualized by fluorescence microscopy, and then black and white images were captured
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with a Spot CCD digital camera before being pseudo-colored and merged with Spot
software V3.5.9 (Diagnostic Instruments Inc.).  FISH hybridization patterns in BrdU-
positive nuclei were scored as single-single (SS, neither allele replicated), single-double
(SD, one allele replicated), or double-double (DD, both alleles replicated).
38
2.3.  RESULTS
Imprinted expression defects in Eednull/null embryos
In order to assess EED’s role in imprinted expression of genes in the KvDMR
cluster, assays were necessary that could discriminate maternal and paternal allele gene
products.  CD1 and JF1 mouse strains are sufficiently diverged from one another such
that polymorphisms are frequently present in the expressed regions of genes, usually in 5’
and 3’ untranslated regions.   Assays were developed that would discriminate alleles on
the basis of those polymorphisms, and RNA was analyzed from CD1.JF1 (F1) wild-type
and Eednull/null E7.5 embryos.
Ascl2, which is also called Mash2, is the most centromeric gene in the KvDMR
cluster (Figure 2.1).  A T/C CD1/JF1 polymorphism was identified in the 3’UTR of
Ascl2, and this SNP was used to assess the status of imprinted expression.  Direct
sequencing of Ascl2 RT-PCR products revealed that the normally silent, paternally-
inherited allele becomes expressed in Eednull/null E7.5 embryos (Figure 2.2A).
Genes within an imprinted cluster are believed to be regulated by common
mechanisms.  As a result, the loss of Ascl2 imprinting observed in Eednull/null embryos
suggested that Eed may be required for imprinting of the entire KvDMR cluster.  Cd81,
also known as Tapa1, is the first gene distal to Ascl2 in the KvDMR cluster (Figure 2.1).
A 5 bp insertion present in the 3’ UTR of the JF1 allele of Cd81 allows maternal and
paternal allele gene products to be discriminated on a single strand conformation
polymorphism gel.  At E7.5, biallelic Cd81 expression was observed in both wild-type
and Eednull/null whole conceptuses, indicating that Cd81 is not imprinted in some tissues at
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these stages (Figure 2.2B).  However, only maternal Cd81 was detected in wild-type E7.5
extraembryonic tissues, demonstrating that Cd81 is imprinted in extraembryonic tissues
at this stage.  Similarly, in Eednull/null E7.5 extraembryonic tissues, expression was only
detected from the maternally-inherited allele, suggesting that Eed is not required for
Cd81 imprinting.
The KvDMR cluster is a large imprinted cluster with a centrally located imprinting
control region (Figure 2.1).  Both Ascl2 and Cd81 are located on the proximal end of the
cluster.  In order to assess the status of imprinted expression of genes closer to the ICR
and genes at the distal end of the cluster, the status of Kcnq1, Msuit, and Tssc3 imprinted
expression were assessed in wild-type and in Eednull/null E7.5 embryos.  Direct sequencing
of RT-PCR products from all three genes revealed monoallelic expression of both wild-
type and  in Eednull/null embryos (Figure 2.2C-E).  Together, these results indicate that Eed
is required for the normal imprinting of Ascl2 but not of several other genes in the
KvDMR cluster.
Imprinted expression analysis in Eedhypo/null embryos
The Eednull allele is an ENU-generated leucine-to-proline substitution in the third
of EED’s five WD-40 motifs [30].  A second, ENU-generated allele, Eedhypo, causes a less
severe phenotype, with homozygous animals exhibiting homeotic skeletal
transformations but surviving to adulthood on outbred backgrounds [30].  Like Eednull/null
embryos, Eedhypo/null embryos have defects in imprinted X-chromosome inactivation [13].
To assess whether Eedhypo/null embryos share the Ascl2 imprinting defects observed in null
embryos, Ascl2 RT-PCR products from wild-type and Eedhypo/null embryos were directly
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sequenced.  However, monoallelic expression was observed in all embryos, suggesting
that Eedhypo retains sufficient activity to silence the paternal allele of Ascl2 (Figure 2.3).
Imprinted expression defects in Eednull/null TS cells
Even though imprinted genes within the same cluster are typically thought to be
coregulated, in E7.5 conceptuses, Eed was required for imprinted expression of Ascl2 but
not of the neighboring Cd81, which is only 84 kb from Ascl2.  Recent work has
demonstrated that Eed is only functionally required for X-chromosome inactivation in a
small subset of extraembryonic cells  [14].  These defects are recapitulated in vitro in
trophoblast stem (TS) cells, a cell line representing primitive, extraembryonic tissues.  If
Eed’s role in imprinting were similarly tissue-specific, our ability to detect imprinting
defects could be obscured by normal imprinted expression in the vast majority of
embryonic cells.  As a result, I re-analyzed imprinted expression of genes in the KvDMR
cluster in wild-type and Eednull/null trophoblast stem (TS) cells.
Consistent with our observations in Eednull/null conceptuses, Ascl2 was biallelically
expressed in Eednull/null TS cells (Figure 2.4A).  To assess the expression of Cd81, I
employed a non-denaturing HPLC assay, in which the mobility of RT-PCR products
through the affinity column is determined by size.  As a result, the larger, maternal JF1
allele of Cd81 elutes later than the smaller CD1 allele.  Although Cd81 was expressed
primarily from the maternal allele in wild-type TS cells, approximately equal levels of
maternal and paternal allele gene product were observed in Eednull/null TS cells,
demonstrating that Eednull/null TS cells have broader imprinting defects than were observed
in Eednull/null conceptuses (Figure 2.4B).
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The gene immediately distal to Cd81 is Tssc4 (Figure 2.1).  Imprinting analyses
of Tssc4 in wild-type and in Eednull/null conceptuses failed to produce definitive results
(data not shown).  In wild-type TS cells, Tssc4 is expressed predominantly from the
maternal allele, with much lower levels of paternal allele gene product (Figure 2.4C).
Conversely, in Eednull/null TS cells, the levels of maternal and paternal allele gene product
were approximately equal, suggesting that Eed is also required for Tssc4 imprinting in
these cells (Figure 2.4C).
PcG proteins have been implicated in stem-cell maintenance, with some results
suggesting that PcG-deficient stem cells may inappropriately differentiate [31-33].  If Eed
mutant TS cells prematurely differentiate and if imprinting were to be relaxed during
differentiation, the imprinting defects observed in Eednull/null TS cells could be due simply
to differences in the differentiation state of wild-type and mutant cells, as opposed to Eed
having a direct role in imprinted expression.  To assess this possibility, we differentiated
wild-type and Eednull/null TS cells by removing Fgf4 and activin from the growth media.
These growth factors are required to prevent TS cells from differentiating and
endoreduplicating both in vivo and in vitro  [28].  Tssc4 imprinting remained intact in
differentiated wild-type TS cells, demonstrating that the observed loss of imprinting in
Eednull/null TS cells is not simply a consequence of premature differentiation (Figure 2.4C).
Ascl2, Cd81, and Tssc4 all reside on the proximal end of the KvDMR imprinting
control region.  To determine whether Eed is also required for imprinted expression of
genes near and distal to the ICR, I assessed expression of Kcnq1, Cdkn1c, Tssc5, and
Tssc3, which represent four of the six known imprinted genes expressed from promoters
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on the distal side of the ICR.  Unlike our observations on the proximal end of the cluster,
Eed was dispensible for imprinted expression of all four of these genes (Figure 2.5A-D).
The KvDMR imprinting control region overlaps with the promoter of the non-
coding RNA Kcnq1ot1, which is the only gene in the cluster expressed exclusively from
the paternally-inherited allele.  Paternally-inherited deletions eliminating the Kcnq1ot1
promoter and mutations prematurely terminating Kcnq1ot1 transcription both disrupt
silencing of the paternal alleles of the maternally-expressed genes in the KvDMR cluster
[21, 25].  These results indicate that the Kcnq1ot1 RNA itself or transcriptional
elongation of that RNA are required for KvDMR cluster imprinting.  To determine
whether defects in Kcnq1ot1 expression or imprinting were responsible for the imprinting
defects in Eed mutant TS cells, I assessed Kcnq1ot1 imprinting in Eednull/null TS cells.
Kcnq1ot1 was expressed exclusively from the paternally-inherited, CD1 allele in both
wild-type and Eednull/null TS cells, and imprinted expression was maintained even upon
differentiation of those cells (Figure 2.5E).
Maintained replication asynchrony in Eednull/null TS cells
In addition to allele-specific gene expression, imprinted genes are characterized
by additional asymmetries, including asymmetric DNA replication timing [34].
Generally, active alleles of imprinted genes replicate early in S-phase, whereas inactive
alleles replicate late during S-phase. Given that an approximately 100 kb region of the
KvDMR cluster from Mash2 to Tssc4 appears to lose its transcriptional imprinting in
Eednull/null TS cells (Figure 2.3A-C), we analyzed the replication behavior of this segment
to determine whether Eed is also required for asynchronous replication of the subdomain.
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These experiments employed a DNA FISH-based assay that allows direct
counting of resolved sister chromatids in actively replicating cells (Figure 2.6A).  In cells
that have replicated neither allele, the FISH probe detects two single dots, corresponding
to each of the two unreplicated, homologous chromosomes.  Conversely, once both
alleles have replicated, the FISH probe detects two double dots, corresponding to the
replicated sister chromatids on both homologous chromosomes.   Finally, if only one of
the two alleles has replicated, the FISH probe detects one single dot and one double dot,
corresponding to one unreplicated homolog and the two sister chromatids of the
replicated homolog, respectively.  This final class, termed “single-double”, is the
informative class in replication asynchrony assays.
Roughly consistent with previous findings, 38% of wild-type S-phase nuclei had a
single-double hybridization pattern with the Mash2-Cd81-Tssc4 probe, and 22% of nuclei
had a single-double hybridization pattern with a probe for Dlx1, a biallelically expressed
and synchronously replicating, control gene [34].  These values establish the behavior of
asynchronously replicating and synchronous replicating genes in my hands.  Surprisingly,
the percentage of cells exhibiting single-double hybridization patterns were
approximately the same in Eednull/null TS cells (22 and 41%, respectively, Figure 2.6B).
These results suggest that Mash2-Cd81-Tssc4 asynchronous replication is not dependent
on Eed.
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2.4.  DISCUSSION
Imprinting is one of the archetypal examples of epigenetic gene regulation in
mammals.  The role of DNA methylation in imprinted gene expression has been
characterized extensively [6-10].  However, the roles of other epigenetic marks, such as
covalent histone modifications, have received less attention.  Here, we have demonstrated
that the PcG gene Eed is required for imprinted expression of several genes in the
KvDMR cluster in both mouse conceptuses and TS cells.
While this work was underway, two groups reported that EED, EZH2, and
H3K27me3 are all enriched on the silent, paternal alleles of several maternally-expressed
genes in the KvDMR cluster in midgestation placental tissues [22, 35].  Together with the
imprinting defects we observed in Eed mutant conceptuses and TS cells, these results
suggest that EED is directly required for imprinting in the KvDMR cluster.  However,
whereas PRC2 subunits and H3K27me3 were enriched throughout the KvDMR in those
studies, the imprinting defects in Eed mutant TS cells reported here were restricted to the
three most proximal genes, Ascl2, Cd81, and Tssc4.  These results suggest that Eed-
independent regulatory mechanisms must be critical for the imprinting of the genes distal
to Tssc4.  The most compelling candidate to fulfill this function is DNA methylation.
Dnmt1 mutant placentas have imprinting defects nearly reciprocal to those observed in
Eed mutant trophoblast stem cells (Figure 2.7)  [22].  Together, these results suggest that
the KvDMR imprinting cluster can be subdivided into two subdomains.  In the proximal
subdomain, PRC2-mediated histone modifications may be the essential epigenetic mark
in extraembryonic tissues, whereas Dnmt1-mediated DNA methylation is likely to fulfill
this function for more distal genes in the cluster.
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The broader imprinting defects in Eednull/null TS cells relative to Eednull/null
conceptuses suggests that Eed’s role in imprinting, like its role in X-chromosome
inactivation, may be tissue specific.  One possible explanation for such tissue specificity
may be that covalent histone modifications are reinforced by DNA methylation to a far
greater extent in embryonic tissues than in extraembryonic tissues.  Mouse
extraembryonic tissues have much lower levels of DNA methylation than embryonic
tissues.  This distinction is a consequence of DNA methylation dynamics during
development [36].  After fertilization, the genome is passively demethylated until
embryonic and extraembryonic lineages are committed at the blastocyst stage.  After
implantation, the embryonic lineages are rapidly remethylated, but the extraembryonic
lineages remain hypomethylated.  As a consequence, covalent histone modifications,
such as PRC2-mediated H3K27me3, may be especially critical in these DNA-
hypomethylated extraembryonic tissues, where the absence of those marks cannot be
overcome by DNA methylation.
Although Ascl2, Cd81, and Tssc4 were all biallelically expressed in Eed mutant
TS cells, the maternal and paternal alleles of these genes continued to replicate
asynchronously.  Accordingly, imprinted gene expression and replication asynchrony are
uncoupled in Eednull/null TS cells, suggesting that the transcriptional machinery and the
replication machinery may recognize distinct epigenetic marks at imprinted loci.
However, this interpretation is complicated by the normal imprinted expression observed
in genes distal to Tssc4.  Mammalian replicons are poorly defined but are frequently as
large as several hundred kilobases [37].  Consequently, it is possible that the origin of
replication for the Eed-regulated genes Ascl2, Cd81, and Tssc4 actually lies in the Eed-
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insensitive distal end of the KvDMR cluster.  The epigenetic marks controlling expression
of those genes remain intact in Eednull/null TS cells and could be responsible for replication
timing at the proximal end of the cluster.  However, asynchronous replication timing and
imprinted gene expression have been truly uncoupled for entire imprinted clusters in
Dnmt1-/- ES cells, suggesting that replication timing and transcriptional imprinting
actually are governed by distinct epigenetic marks [38].
The work included in this chapter suggests that PRC2-mediated H3K27me3 is
required to silence the paternal alleles of genes at the proximal end of the KvDMR cluster.
However, EZH2, not EED, is not directly responsible for PRC2-mediated H3K27me3,
and in this chapter, we have not demonstrated that EED is required for the catalytic
activity of the complex.  That possibility is explored in Chapter 3.
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FIGURE 2.1.  Schematic illustration of the KvDMR imprinting cluster
Depicted is the KvDMR imprinting cluster on mouse chromosome 7.  The two most
proximal genes, Obph1 and Nap1l4, were not analyzed and are not included on the
diagram.  On the maternally-inherited chromosome (maternal- above), the noncoding
RNA Kcnq1ot1 is silenced, but all other genes in the cluster are expressed.  On the
paternally-inherited chromosome (paternal- below), Kncq1ot1 is expressed, and all other
genes in the cluster are silenced.
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FIGURE 2.2.  Imprinted expression analysis in Eednull/null E7.5 conceptuses and
extraembryonic tissues
Imprinted expression analysis in wild-type (wt or +/+) and Eednull/null (mut or null/null)
CD1.JF1 (F1) E7.5 embryos (A)  Direct sequencing of Ascl2 RT-PCR products. (B)
Single Strand Conformation Polymorphism gel analysis of Cd81 imprinting.  A 5 bp
insertion in the JF1 paternal allele (p) makes that band run more slowly than the smaller
CD1 maternal allele (m).  Unless otherwise indicated, samples were prepared from whole
conceptuses.  Samples prepared from dissected extraembryonic tissues are indicated by
“Ex. Em.”  (C)  Direct sequencing of Kcnq1 RT-PCR products.  (D)  Direct sequencing
of Msuit RT-PCR products.  (E)  Direct sequencing of Tssc3 RT-PCR products.
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FIGURE 2.3. Imprinted expression analysis in Eedhypo/null conceptuses
Ascl2 imprinted expression analysis in wild-type and Eedhypo/null CD1.JF1 (F1) E9.5
embryos by direct sequencing.  The amplicon is the same as that used in Figure 2.2A.
However, the forward primer was used for sequencing here, and the reverse primer was
used there.
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FIGURE 2.4.  Loss of imprinting in Eednull/null  trophoblast stem (TS) cells
Imprinted expression analysis in wild-type (wt) and Eednull/null (mut) JF1.CD1 (F1)
trophoblast stem cells.  (A)  Direct sequencing of Ascl2 RT-PCR products.  (B)  Cd81
imprinted expression assessed by non-denaturing HPLC of RT-PCR products.  The
smaller, CD1 paternal allele (pat) elutes from the column after approximately 3 minutes,
and the larger, JF1 maternal allele (mat) elutes at approximately 3.75 minutes.  (C)  Tssc4
imprinted expression utilizing a JF1-CD1 AluI RFLP.  Maternally-encoded, JF1 RT-PCR
products are cut, but paternally-encoded, CD1 RT-PCR products are not.
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FIGURE 2.5.  Maintained imprinting in Eednull/null  trophoblast stem (TS) cells
Imprinted expression analysis in wild-type (wt) and Eednull/null (mut) JF1.CD1 (F1)
trophoblast stem cells.  (A) Kcnq1 imprinted expression utilizing an AluI RFLP.
Paternally-encoded, CD1 RT-PCR products are cut, but maternally-encoded, JF1 RT-
PCR products are not.  (B)  Cdkn1c imprinted expression analysis using a Tsp509I RFLP.
Paternally-encoded, CD1 RT-PCR products are cut, but maternally-encoded, JF1 RT-
PCR products are not.  (C)  Tssc5 imprinted expression analysis using a NdeI RFLP.
Maternally-encoded, JF1 RT-PCR products are cut, but paternally-encoded, CD1 RT-
PCR products are not.  (D)  Direct sequencing of Tssc3 RT-PCR products.  (E)  Kcnq1ot1
imprinted expression analysis utilizing a HpyCH4IV RFLP.  The paternally-encoded,
CD1 RT-PCR products are cut, but the maternally-encoded, JF1 RT-PCR products are
not.
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FIGURE 2.6.  Maintained replication asynchrony in the KvDMR imprinted cluster
in Eednull/null  TS cells
Replication asynchrony assessed in wild-type and in Eednull/null  TS cells.  (A)
Fluorescence microscopy images of S-phase nuclei hybridized with DNA FISH probes.
When neither allele has replicated, two single dots are observed (Single-Single).  When
one allele has not replicated but one allele has replicated, one single dot and one double
dot are observed (Single-Double).  After both alleles have replicated, two double dots are
observed (Double-Double).  The Single-Double class is a readout of replication
asynchrony.  (B)  Results of replication asynchrony assays in wild-type and in Eednull/null
TS cells.  22% of both wild-type and Eednull/null  S-phase nuclei exhibit Single-Double
staining patterns with a probe to Dlx1, a known synchronously replicating control gene.
Conversely, 38% of wild-type and 41% of Eednull/null  S-phase nuclei exhibit Single-
Double staining patterns with a probe corresponding to the Ascl2-Cd81-Tssc4 region of
the KvDMR cluster.
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FIGURE 2.7.  Summary of imprinting defects in Eednull/null TS cells and in
Dnmt1null/null placentas
Imprinting defects previously reported in DNA methyltransferase 1 (Dnmt1) mutant
placentas and reported here in Eednull/null TS cells [22].  Dnmt1 and Eed are required to
regulate nearly reciprocal groups of genes, although the centrally located Kcnq1 is
imprinted normally in both cases.
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3.1.  SUMMARY
PcG proteins mediate heritable transcriptional silencing by generating and
recognizing covalent histone modifications.  One conserved PcG complex, PRC2, is
composed of several proteins including the histone methyltransferase (HMTase) Ezh2,
the WD-repeat protein Eed, and the Zn-finger protein Suz12.  Ezh2 methylates histone
H3 on lysine 27 (H3K27) [1-4], which serves as an epigenetic mark mediating silencing.
H3K27 can be mono-, di-, or trimethylated (H3K27me1, H3K27me2, and H3K27me3,
respectively) [5].  Hence, either PRC2 must be regulated so as to add one methyl group to
certain nucleosomes but two or three to others, or distinct complexes must be responsible
for H3K27me1, H3K27me2, and H3K27me3.  Consistent with the latter possibility,
H3K27me2 and H3K27me3, but not H3K27me1, are absent in Suz12-/- embryos, which
lack both Suz12 and Ezh2 protein [6].  Mammalian proteins required for H3K27me1
have not been identified.  Here, we demonstrate that, unlike Suz12 and Ezh2, Eed is
required not only for H3K27me2 and H3K27me3 but also global H3K27me1.  These
results provide a functionally-important distinction between PRC2 complex components
and implicate Eed in PRC2-independent histone methylation.
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3.2.  RESULTS
Reduced Histone H3 K27 Methylation in Eednull/null cells
To assess Eed’s role in H3K27 methylation, H3K27me1, H3K27me2, and
H3K27me3 were analyzed by immunofluorescence in wild-type and Eedl7Rn5-3354SB
homozygous (herein referred to as Eednull/null ) embryonic stem (ES) cells and trophoblast
stem (TS) cells.  Consistent with published reports from Eednull/null  embryos [7],
H3K27me3 was undetectable in Eednull/null  ES cells and TS cells (Figures 3.1C,F).
Additionally, H3K27me1 and H3K27me2 were also undetectable in Eednull/null  ES cells
and TS cells (Figure 3.1A,B,D,E).  However, no difference in trimethylation of histone
H3 lysine 9 staining was observed between wild-type and Eednull/null TS and ES cells (data
not shown), suggesting that the defect is specific to H3K27 methylation.
To confirm the immunofluorescence data, histones were isolated from wild-type
and Eednull/null ES cells by acid extraction, and H3K27 methylation was analyzed by
Western blotting.  H3K27me1, H3K27me2, and H3K27me3 were all dramatically
reduced in Eednull/null ES cells (Supplementary Figure 3.1). These results implicate Eed not
only in di- and trimethylation of H3K27, as had previously been suggested for other
PRC2 subunits, but also in monomethylation of H3K27.
Reduced Ezh2 Subunit Protein Levels in Eednull/null ES cells
To gauge the molecular basis for the loss of H3K27 methylation in Eednull/null cells,
Eed and Ezh2 subunit protein levels were compared in wild-type and Eednull/null ES cells
by Western blotting.  Consistent with the genetic classification of Eednull as a null allele,
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Eed protein is nearly undetectable in Eednull/null ES cells (Figure 3.2A) and in Eednull/null TS
cells (data not shown).
Suz12-/- embryos lack not only Suz12 but also Ezh2, suggesting that the stability
of Ezh2 may be dependent upon its incorporation into a functional PRC2 complex [6].
Similarly, Ezh2 protein levels were dramatically reduced in Eednull/null ES cells (Figure
3.2A) and in Eednull/null TS cells (data not shown).
Despite the dramatic reduction in Eed and Ezh2 protein levels in Eednull/null ES
cells, the mRNA levels of both gene products were unchanged (Figure 3.2B-D).
Together, these results suggest that Ezh2 is unstable outside of intact PRC2 complexes.
Eed Rescues H3K27 Methylation Defects in Eednull/null ES Cells
To confirm Eed’s role in mono-, di- and trimethylation of H3K27 and to assess
whether Eed is involved not only in the maintenance of these marks but also in their de
novo establishment, Eednull/null ES cells were transiently transfected with plasmids
expressing Eed or Eednull full length cDNAs containing all four putative Eed translation
start sites [8].  Expression of Eed but not Eednull rescued the H3K27 methylation defects
in a subset of Eednull/null ES cells  (Figure 3.3. and Supplementary Figures 3.2 and 3.3).
We hypothesized that the subpopulation of rescued cells represent the successfully
transfected cells in each population.  Consistent with this interpretation, the H3K27me1
defect was uniformly rescued in Eednull/null ES cells stably expressing wild-type Eed
(Figure 3.3).
Surprisingly, no H3K27me2 or H3K27me3 rescue was observed in these stable
lines (Supplementary Figures 3.2 and 3.3).  However, similar to the parental line,
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transient transfection of these lines with the Eed-expression plasmid successfully rescued
the H3K27me2 and H3K27me3 defects in a fraction of cells, confirming that the stable
lines remain competent for di- and trimethylation (Supplementary Figures 3.2 and 3.3).
We hypothesized that the discrepancy in H3K27 methylation in transient versus stable
lines might reflect differences in Eed expression levels.  Supporting this hypothesis,
much higher levels of Eed were observed in transient lines than in stable lines, even
though only a fraction of the cells in the transiently transfection receive the Eed-
expression plasmid (Figure 3.4A).  Additionally, consistent with previous data
demonstrating that Ezh2 is dispensable for H3K27me1 but required for H3K27me2 and
H3K27me3 [6], Ezh2 protein levels were rescued in transient but not stable lines (Figure
3.4A).
Eed, Eedhypo, and Eednull protein levels correlate with phenotypic severity
Whereas Eednull/null embryos die during embryogenesis at gastrulation stages,
animals homozygous for a hypomorphic allele, Eedl7Rn5-1989SB (herein referred to as
Eedhypo/hypo), are viable and fertile but are runted and exhibit skeletal transformations [9].
Despite this dramatic phenotypic difference, no biochemical features have been identified
that distinguish Eedhypo and Eednull proteins [10-12].  To determine whether complexes
containing Eedhypo mediate H3K27 methylation, Eednull/null ES cells were transiently
transfected with plasmids expressing Eedhypo.  Consistent with the mild phenotype of
Eedhypo/hypo animals, Eedhypo, like Eed but unlike Eednull, was able to rescue the H3K27
methylation defects in a percentage of Eednull/null ES cells (Figure 3.3, Supplementary
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Figures 3.2 and 3.3).  Additionally, Eedhypo/hypo fibroblasts retain H3K27me1, H3K27me2,
and H3K27me3 (data not shown).
Eedhypo’s ability to mediate H3K27 methylation suggests that, unlike Eednull,
Eedhypo must be stable. In order to assess the relative stability of Eedhypo and Eednull,
Eednull/null ES cells were transiently transfected with plasmids expressing Eed, Eedhypo, or
Eednull.  Consistent with the hypomorphic phenotype conferred by the mutation, Western
blotting of whole cell lysates from transfected cells indicated that the Eedhypo protein is
present at a level intermediate to Eed and Eednull (Figure 3.4B).  Although reduced
relative to wildtype, the level of Eedhypo on a per cell basis is apparently sufficient for
assembly of functional PRC2 complexes.  However, the qualitative nature of the
immunofluorescence assay precluded determination of whether Eedhypo mediates
qualitatively less H3K27 methylation than Eed.
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3.3.  DISCUSSION
The requirement of Eed for global  H3K27me1, H3K27me2, and H3K27me3
suggests either that PRC2 is necessary for all H3K27 methylation or that distinct Eed-
containing complexes mediate mono-, di- and trimethylation.  In support of the former
concept, the Drosophila Ezh2 homologue E(z) was recently shown to be required for
H3K27me1, H3K27me2, and H3K27me3  [13], suggesting that all H3K27 methylation is
mediated by PRC2 in that organism.  However, in mammals, the mechanism may be
more complex.  Suz12-/- embryos, which lack Suz12 and Ezh2 but retain Eed, maintain
H3K27me1 [6].  These results indicate that PRC2 may mediate only H3K27me2 and
H3K27me3 in mammalian cells.  This model is similar to H3K9 methylation, where
distinct enzymes mediate mono/dimethylation and trimethylation [5].
Importantly, the persistence of Eed in Suz12-/- embryos, which also retain
H3K27me1, and the absence of H3K27me1 in Eednull/null cells are consistent with the
possibility that Eed associates with a PRC2-independent H3K27 monomethylase.  This
interpretation is supported by the observation that H3K27me1 is rescued in Eednull/null ES
lines stably expressing low levels of Eed independent of any rescue of Ezh2 protein
levels.  It is unclear why the low level of Eed in the stable rescue lines failed to stabilize a
corresponding level of Ezh2.  However, one interpretation of these results is that, when
levels of Eed are limiting, Eed is preferentially assembled into the proposed
monomethylase complex.
The extensive covalent modifications on histone amino-terminal tails have been
proposed to serve as a histone code that controls chromatin conformations and
transcriptional states [14, 15].  The complexity of this code is a product not only of the
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large number of modified residues and the diverse types of chemical modifications
(acetylation, methylation, phosphorylation, etc.) but also the different number of
chemical moieties added to a particular residue.  H3K27me3 recruits a second PcG
complex, PRC1, which condenses local chromatin [1, 4, 16, 17].  However, the functions
of H3K27me1 and H3K27me2 are undefined.  The involvement of Eed in all three forms
of methylation suggests that the marks may be functionally related, perhaps reflecting
that H3K27me1 is a primed state that facilitates H3K27me2 and H3K27me3.  In this
model, Eed could bridge PRC2 and the putative monomethylase complex.  Alternatively,
H3K27me1 may itself be a functional mark, and preliminary analyses suggest that the
presence of H3K27me1 alone in our stable lines is sufficient to rescue a subset of
morphological defects in mutant cells (N.D.M., D.Y., and T.M., unpublished
observations).
While Ezh2 clearly provides catalytic activity to PRC2, the functional roles of the
noncatalytic subunits remain largely undefined.  Eednull protein is unable to bind Ezh2
[11, 12].  Here, we demonstrate that Ezh2 protein levels are dramatically reduced in
Eednull/null cells.  Together these results suggest that Ezh2 is unstable outside of functional
PRC2 complexes.  The S. cerevisiae WD-repeat protein Swd2p is similarly required for
the stability of the HMTase Set1p, perhaps reflecting a more general requirement for
WD-repeat proteins in the stable assembly of HMTase complexes [18].
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3.4.  MATERIALS AND METHODS
Immunofluorescence
Eednull/null ES cell line 21 and wild-type (Eed+/+) ES cell line 25.5  [19] or Eednull/null
TS cell line 3-5 and wild-type (Eed+/null) TS cell line 5-4 were grown on irradiated
fibroblast feeders, plated onto coverslips without feeders, and grown to subconfluency.
For immunofluorescence of transfected cells, ES cells were passaged two times without
fibroblast feeders, plated onto coverslips and subsequently transfected with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA).
Coverslips and attached cells were treated with CSK buffer (100 mM NaCl,
300mM sucrose, 3mM MgCl2, 10mM PIPES pH=6.8) containing 0.5% Triton-X, fixed in
4% paraformaldehyde/1X PBS, and stored in 1X PBS, 0.2% Tween-20.  Subsequently,
cells were washed in 1X PBS and incubated in a humid chamber with blocking buffer
(1X PBS, 5% goat serum, 0.2% Tween-20, 0.2% Fish skin gelatin).  Blocked samples
were incubated in a humid chamber with primary antibodies (anti-H3K27me1 (Upstate,
Charlottesville, VA), anti-H3K27me2 [5], and anti-H3K27me3 [5]) diluted 1:250 in
blocking buffer.  Then, the cells were washed in 1XPBS/0.2% Tween-20, blocked again
in blocking buffer, and incubated in a humid chamber with secondary antibody (Goat
anti-Rabbit Alexa 594, Molecular Probes, Eugene, OR).  Finally, samples were washed in
1XPBS/0.2% Tween-20, and mounted with Vectashield (Vector Laboratories,
Burlingame, CA).  Stained slides were visualized by fluorescence microscopy.
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Plasmid Construction and Generation of Stable Lines
Full length Eed, Eedhypo, and Eednull cDNAs were cloned into the mammalian
expression vector pTarget (Promega, Madison, WI) by conventional molecular biology
techniques.  For generation of stable lines, the full length Eed cDNA was subcloned into
pcDNA3.1/Hygro (Invitrogen, Carlsbad, CA) to generate pNDM45.
PNDM45 was linearized by BglII restriction digest and electroporated into
Eednull/null ES cell line 21.  Clones stably expressing Eed were picked after eight days of
hygromycin selection.  Incorporation of the transgene was confirmed by PCR.
Coomassie Staining and Western blotting
For histone isolation, 1-2 x 107 ES cells were harvested and lysed with 0.002%
NP-40.  Nuclei were isolated by gentle centrifugation and then lysed in 0.4 N sulfuric
acid.  Nuclear proteins were precipitated with 20% trichloroacetic acid, washed in
acetone, and resuspended in sterile water.  For all other protein isolation, ES or TS cells
were grown to near confluency in 35mm dishes.  Whole cell lysates were generated by
lysing in urea lysis buffer (7.75M Urea, 0.01M Tris pH=8, 0.1M NaH2PO4).
For Coomassie staining, histone preparations from wild-type and Eednull ES cells
were electrophoresed on a 15% SDS-PAGE gel.  Gels were then washed in water, stained
1 hour in Simply Blue SafeStain (Invitrogen, Carlsbad, CA), and then destained
overnight in distilled water.
For Western blotting, protein preparations were separated on 10% (for nonhistone
proteins) or 15% (for histone proteins) SDS-PAGE gels in Tris-Glycine.  Subsequently,
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proteins were transferred to Immun-Blot PVDF membranes (BIO-RAD, Hercules, CA)
in Tris-Glycine-Methanol Transfer Buffer.  Membranes were blocked in 4-5% nonfat
dried milk in TBST (50mM Tris-HCl pH = 7.4, 150 mM NaCl, 0.1% Tween-20), and
then probed overnight at 4°C with primary antibodies diluted in blocking buffer (anti-Eed
[20], anti-Ezh2 [20], anti-Actin (Santa Cruz Biotechnology, Santa Cruz, CA), anti-
H3K27me1 (Upstate, Charlottesville, VA), anti-H3K27me2 [5], and anti-H3K27me3
[5]).  Subsequently, blots were washed in TBST, and then probed overnight at 4°C with
appropriate HRP-conjugated secondary antibodies (Pierce, Rockford, IL).  Blots were
washed first in TBST and then in TBS (50mM Tris-HCl pH = 7.4, 150 mM NaCl), before
detecting secondary antibodies with SuperSignal West Dura Extended Duration
Substrate (Pierce, Rockford, IL).  Finally, blots were exposed to film, which was then
developed.
Northern blotting
Triplicate samples of wild-type and Eednull/null ES cells were harvested and lysed
directly in TRIzol Reagent (Invitrogen, Carlsbad, CA).  RNA was isolated from the
TRIzol lysate by phenol-chloroform extraction, and RNA was precipitated with
isopropanol.  Precipitated nucleic acids were washed in 70% ethanol and resuspended in
sterile water.  Isolated RNAs were electrophoresed in 1X MOPS (20 mM MOPS, 50 mM
sodium acetate, 1 mM EDTA, pH=7), formaldehyde, agarose gels, and then, RNA was
transferred to Nytran SuperCharge membranes (Schleicher & Schuell, Keene, NH) in
10X SSC (1.5 M NaCl, 150mM Na3C6H5O7, pH=7).
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Radiolabeled Northern probes were generated by incubating the full length Eed
cDNA or a fragment of the Gapdh cDNA with random hexamers, dTTP, dATP, dGTP,
α-32P dCTP, and Klenow enzyme (New England Biolabs, Beverly, MA). Labeled probes
were purified from unincorporated nucleotides using ProbeQuant G-50 Micro Columns
(Amersham Biosciences, Amersham, UK).
Blots were prehybrdized at 65°C for 1-2 hours in Church buffer (1% BSA, 1mM
EDTA, 0.5M NaPO4, 7% SDS) and then hydridized at 65°C overnight with radiolabeled
probe diluted in Church buffer.  Subsequently, blots were washed in 0.2X-2X SSC, 0.1%
SDS at 65°C and then exposed to film overnight at -80°C.
RealTime RT-PCR
RNA was isolated from triplicate samples of wild-type and Eednull/null ES cells
using TRIzol Reagent (Invitrogen, Carlsbad, CA) as above, and contaminating DNA
was eliminated by treating with DNase for one hour at 37°C.  cDNA was prepared using
SuperScriptII Reverse Transcriptase (Invitrogen, Carlsbad, CA) and then analyzed by
RealTime PCR for Ezh2 and Hprt cDNA.  Ezh2 CT values were normalized to Hprt CT
values.
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FIGURE 3.1.  Loss of H3K27 Methylation in Eednull/null ES and TS cells
Immunofluorescence analysis of (A and D) H3K27me1, (B and E) H3K27me2, and (C
and F) H3K27me3 in wild-type and Eednull/null ES (A-C) and TS (D-F) cells. ES and TS
cell colonies indicated by arrows.  Examples of wild-type irradiated fibroblast feeders,
which serve as internal controls for the staining, indicated by asterisks.   The specificity
of the methyl-specific antibodies have been previously demonstrated [5].
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FIGURE 3.2.  Reduced Eed and Ezh2 Protein Levels but Normal mRNA Levels in
Eednull/null ES cells
(A)  Whole cell lysates from wild-type or Eednull/null  ES cells analyzed by Western
blotting with antibodies detecting Eed or Ezh2.  Equal loading was verified by blotting
with an antibody detecting Actin.  (B)  Eed and Gapdh Northern blots.  (C)  Eed mRNA
levels relative to Gapdh mRNA levels. Eed+/+ values were set to 1.0.  (D)  RealTime PCR
analysis of Ezh2 mRNA. Wild-type values were set to 1.0.
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FIGURE 3.3.  Defect in H3K27me1 Methylation in Eednull/null ES Cells is Rescued by
Wild-Type Eed
Immunofluorescence analysis of H3K27me1 in wild-type ES cells (top panels), in
Eednull/null ES cells either mock transfected (second panels) or transfected with plasmids
expressing Eed (third panels), Eedhypo (fourth panels), or Eednull (fifth panels), and in
Eednull/null ES cells stably expressing Eed (bottom panels).
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FIGURE 3.4.  Eed and Ezh2 Protein Levels in Rescue Lines
(A) Whole cell lysates from wild-type ES cells (+/+), Eednull/null  ES cells (null/null),
Eednull/null  ES cells stably expressing Eed (stable), or Eednull/null  ES cells transiently
transfected with an Eed expression plasmid (transient) analyzed by Western blotting with
antibodies detecting Eed, Ezh2, or Actin.  Low levels of Eed protein in Eednull/null  ES cells
may reflect a small amount of residual mutant protein or feeder contamination.  (B)
Eednull/null ES cells were cotransfected with a Gfp expressing plasmid and either mock or
plasmids expressing Eed, Eedhypo, or Eednull.  Transfections efficiencies were controlled by
Gfp fluorescence, and whole cell lysates were analyzed by Western blotting with anti-
Eed antibodies. Equal loading was verified by blotting with an antibody detecting Actin.
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SUPPLEMENTARY FIGURE 3.1.  Western Blot Confirmation of H3K27
Methylation Defects  in Eednull/null ES cells
Acid-extracted histones from wild-type and Eednull/null ES cells were analyzed by Western
blotting with antibodies recognizing H3K27me1, H3K27me2, and H3K27me3.  Equal
loading was verified by Coomassie stain.
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SUPPLEMENTARY FIGURE 3.2.  Defect in H3K27me2 Methylation in Eednull/null
ES  Cells is Rescued by Wild-Type Eed
Immunofluorescence analysis of H3K27me2 in wild-type ES cells (top panels), in
Eednull/null ES cells either mock transfected (second panels) or transfected with plasmids
expressing Eed (third panels), Eedhypo (fourth panels), or Eednull (fifth panels), in Eednull/null
ES cells stably expressing Eed (sixth panels), and in Eednull/null ES cells stably expressing
Eed and transiently transfected with a plasmid expressing Eed (bottom panels).
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SUPPLEMENTARY FIGURE 3.3.  Defect in H3K27me3 Methylation in Eednull/null
ES Cells is Rescued by Wild-Type Eed
Immunofluorescence analysis of H3K27me3 in wild-type ES cells (top panels), in
Eednull/null ES cells either mock transfected (second panels) or transfected with plasmids
expressing Eed (third panels), Eedhypo (fourth panels), or Eednull (fifth panels), in Eednull/null
ES cells stably expressing Eed (sixth panels), and in Eednull/null ES cells stably expressing
Eed and transiently transfected with a plasmid expressing Eed (bottom panels).
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MOLECULAR AND FUNCTIONAL MAPPING OF ISOFORM START SITES
AND MOTIFS IN THE POLYCOMB GROUP PROTEIN EED
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4.1.  ABSTRACT
Polycomb Group (PcG) proteins represent a conserved family of developmental
regulators that mediate heritable transcriptional silencing by modifying chromatin states.
One PcG complex, the PRC2 complex, is composed of several proteins, including the
histone H3 lysine 27 (H3K27) methyltransferase EZH2 and the WD-repeat protein EED.
Histone H3K27 can be mono- (H3K27me1), di- (HeK27me2), or trimethylated
(H3K27me3).  However, it remains unclear what regulates the number of methyl groups
added to H3K27 in a particular nucleosome.  In mammalian cells, EED is present as four
distinct isoforms, which are believed to be produced by utilizing four distinct, in-frame
translation start sites in a common Eed mRNA.  To assess the roles of individual EED
isoforms in H3K27 methylation, we characterized three of the four EED isoform start
sites and demonstrated that individual isoforms are not necessary for H3K27me1,
H3K27me2, or H3K27me3.  Instead, the core WD-40 motifs and the histone binding
region of EED alone are sufficient to mediate all three marks, demonstrating that EED
isoforms do not control the enzymatic activity of the PRC2 complex.
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4.2.  INTRODUCTION
Polycomb Group (PcG) proteins are a conserved family of development
regulators that modify chromatin states in order to mediate heritable transcriptional
silencing.  PcG-mediated repression is important in diverse biological processes
including X-chromosome inactivation, genomic imprinting, and segmental patterning [1-
9].  One PcG complex, the PRC2 complex, is composed of several bona fide PcG
proteins, including the histone H3 lysine 27 (H3K27) methyltransferase EZH2 and the
WD-repeat protein EED [9-12].
Four EED isoforms are found in mammals, and these isoforms are thought to be
produced by utilizing four in-frame translation start sites in the Eed mRNA [13].  The
identities of those sites were postulated on the basis of in vitro translation studies, which
were supported by subsequent immunoblotting experiments with antibodies raised to
peptides predicted to be present in some but not other isoforms [13, 14].  However, the
four putative start sites have not been demonstrated formally in vivo.
Although most proteins initiate translation at methionine-encoding AUG codons,
an increasing number of proteins are recognized to initiate translation from non-AUG
codons.  Often, these alternative start sites generate upstream isoforms of proteins also
translated from downstream, canonical AUG initiation codons, and typically, the
alternative codons differ from the canonical AUG sequence at only one of the three
nucleotide positions [15, 16].  For instance, Fibroblast Growth Factor-2 (FGF2) is present
as five isoforms in mammalian cells, with four CUG initiation codons upstream of a
canonical AUG start site, and Vascular Endothelial Growth Factor (VEGF) is translated
from both an upstream CUG and a downstream AUG [17-21].  Translation of the putative
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EED isoforms appears to be consistent with both of these trends as well.  The upstream
EED-1 and EED-2 are postulated to initiate translation from non-canonical GUG codons
at positions 169-171 and 274-276 in the Eed cDNA, respectively, and the putative start
sites for EED-3 and EED-4 are canonical AUG sequences at positions 451-453 and 493-
495 [13, 14].
EED isoform usage is regulated developmentally, and EED-2, which has only
been observed in undifferentiated stem cells and in tumors, has been proposed to be
important in maintaining developmental plasticity [22].  However, definitive biochemical
functions of the various EED isoforms have not been demonstrated.  Previous work
postulated that EED isoforms control the substrate specificity of the PRC2 complex.  In
those initial studies, the largest isoforms, EED-1 and EED-2 appeared to direct EZH2
methyltransferase activity towards histone H1K26, whereas EED-3 and EED-4 appeared
to direct EZH2 methyltransferase activity towards H3K27 [13].  However, a second
recent study failed to confirm these findings [23].
Histone H3K27 can be mono- (H3K27me1), di- (HeK27me2), or trimethylated
(H3K27me3)[24].  H3K27me3 is a repressive histone modification that localizes to
confirmed targets of PcG silencing, including the inactive X-chromosome[1, 2, 25-27].
H3K27me3 mediates its repressive effect by recruiting to chromatin or at least stabilizing
the association of a second PcG complex, PRC1 [28-31].  Conversely, the functions of
H3K27me1 and H3K27me2 are not known.  Moreover, it remains unclear what regulates
the number of methyl groups added to H3K27 in a particular nucleosome.  Two
simplistic models have been proposed to explain this specificity [32].  The first model
proposes that distinct methyltransferases or distinct complexes mediate each H3K27
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methylation state.  In the second model, a single methyltransferase is responsible for all
three methylation states but is somehow regulated so as to add one methyl group to
certain nucleosomes and two or three methyl groups to others.
Because all four known EED isoforms associate with EZH2 [13, 22], we
examined whether these isoforms might control the number of methyl groups added to
H3K27 in a particular nucleosome.  In the present study, we definitively characterize
three of the four EED isoform start sites and demonstrate that individual isoforms are not
necessary for H3K27me1, H3K27me2, or H3K27me3.  Instead, EED’s core WD-40
motifs and histone binding region alone are sufficient to mediate all three marks,
demonstrating that EED isoforms do not control the enzymatic activity of the PRC2
complex.
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4.3.  METHODS AND MATERIALS
Cell lines and culture
CD1 murine embryonic fibroblasts (MEFs) were plated on gelatin-coated
coverslips and grown to subconfluency.  Wild-type embryonic stem (ES) cell line 25.5
and Eedl7Rn5-3354SB/l7Rn5-3354SB (herein referred to as Eed mutant or Eed-/-) ES cell line 21 were
grown first on irradiated fibroblast feeders before being plated on coverslips without
feeders and grown to subconfluency [33].  In transfection experiments, ES cells plated on
coverslips were transfected using Lipofectamine 2000™ (Invitrogen) and harvested 48
hours later.
Immunofluorescence
Cells on coverslips were permeabilized with CSK buffer (100 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, 10 mM PIPES [pH 6.8]) and fixed in 4% paraformaldehyde.  To
stain, cells were washed in phospho-buffered saline (PBS) and incubated with blocking
buffer (PBS, 5% goat serum, 0.2% Tween-20, 0.2% fish skin gelatin).  After blocking,
samples were incubated with primary antibody (anti-H3K27me1 [Upstate], anti-
3mK27me2[24], anti-3mK27me3[24], or anti-HP1-∝ [Upstate]), which had diluted 1:250
in blocking buffer.  Subsequently, cells were washed in PBS/0.2% Tween-20 and then
incubated with secondary antibody (Goat anti-Rabbit Alexa 594 [Molecular Probes])
diluted 1:250 in blocking buffer.  Blocking and antibody incubations were always
performed in a humid chamber at 37° C.  Subsequently, cells were washed again in
PBS/0.2% Tween-20 and mounted with Vectashield™ containing 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Vector Laboratories).  Stained slides were
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visualized by fluorescence microscopy, and then black and white images were captured
with a Spot CCD digital camera before being pseudo-colored and merged with Spot
software V3.5.9 (Diagnostic Instruments Inc.).
Plasmid Construction
Constructs expressing mes-6, esc, escl, or Eed cDNAs were cloned into the shuttle
TA-cloning vector pGEM®-T Easy (Promega) and then subcloned into EcoRI-digested
pTarget™ (Promega) by conventional molecular biology techniques.  The orientation and
identity of all inserted sequences were confirmed by fully sequencing the cDNA and the
cloning junctions.
Eed cDNAs were truncated by PCR, utilizing forward primers that annealed
within the Eed cDNA and reverse primers anchored in pTarget (primer sequences
available upon request).  Site-directed point mutations were generated by standard
methods.  Briefly, primers spanning EED-3 and EED-4 start sites but harboring
ATG→ATA mutations were used as forward primers with a reverse primer anchored in
the pTarget.  Finally, in order to engineer strong translation start sites, in frame consensus
Kozak-(GCCACC)ATG 5’ extensions were included on forward primers.
Western blotting
Wild-type ES cell line 25.5, wild-type ES cell line E14 [34], mock-transfected
Eed mutant ES cell line 21, and Eed mutant ES cell line 21 transfected with various
expression constructs were harvested in urea lysis buffer (7.5 M Urea, 0.01 M Tris [pH
8.0]), 0.1M NaH2PO4) 48 hours after transfection.  Urea-lysates were also harvested from
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mouse Wap-T121 mammary tumor tissue, which is generated by tissue-specific expression
of T121, a fragment of SV40 T antigen that interferes with the function of Retinoblastoma-
family proteins [35].   Proteins were separated on 10% SDS-PAGE gels in Tris-Glycine
running buffer and transferred to Immun-Blot PVDF membranes (Bio-Rad) in Tris-
Glycine Methanol transfer buffer.  Membranes were blocked in 5% non-fat dried milk
(NFDM [Food Lion])/TBST (50 mM Tris HCl [pH 7.4], 150 mM NaCl, 0.1% Tween-20)
and then incubated overnight at 4° C with a mouse monoclonal anti-EED antibody [36]
diluted 1:400 in 3% NFDM/TBST.  Membranes were vigorously washed in TBST and
then incubated overnight at 4° C with HRP-conjugated goat anti-rabbit antibody (Pierce)
diluted 1:3000 in 5% NFDM/TBST.  Membranes were then vigorously washed in TBST
and TBS (50 mM Tris HCl [pH 7.4], 150 mM NaCl), before adding SuperSignal West
Dura Extended Duration Substrate (Pierce) developing reagents.  Finally, blots were
exposed to film and developed.
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4.4.  RESULTS
Distinct localization of H3K27 methylation states
Unlike mouse stem cell lines, differentiated mouse cells, such as murine
embryonic fibroblasts (MEFs,) have a striking nuclear architecture, in which regions of
the genome packaged as part of the pericentric heterochromatin are clearly visible by
DAPI staining as DNA-rich foci.   Using this characteristic DNA staining pattern to
provide landmarks, we assessed the localization of H3K27me1, H3K27me2 and
H3K27me3 in CD1 MEFs (Figure 4.1).  As previously reported, H3K27me1 appeared to
be enriched in the DNA-rich pericentric heterochromatin (Figure 4.1A and[24]).
Conversely, H3K27me2 and H3K27me3 were specifically excluded from these regions,
instead staining in a pattern reciprocal to that of H3K27me1 (Figures 4.1B and 4.1C).
HP1-α, an established marker of pericentric heterochromatin[37-39], was also enriched
in the DNA-rich foci, confirming the identity of these regions (Figure 4.1D).  Finally,
H3K27me2 and H3K27me3 staining patterns were distinguished by the characteristic
enrichment of H3K27me3 on the inactive X-chromosome (Figure 4.1B and 4.1C).
Characterization of EED isoforms expressed in wild-type ES cells
The distinct localization patterns of the three H3K27 methylation states indicates
that the number of methyl groups added to H3K27 in a particular nucleosome is a
regulated process.  Given the existence of three H3K27 methylation states and four EED
isoforms, candidates to control this specificity include the EED isoforms themselves.  To
test this possibility, we aimed to rescue Eed mutant embryonic stem (ES) cells, which
lack detectable levels of endogenous H3K27me1, H3K27me2, and H3K27m3 [32], with
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constructs expressing individual EED isoforms.  However, before a systematic series of
rescue experiments was performed, we attempted to confirm the identities of the EED
isoforms.
Previous work indicates that all four EED isoforms are present in wild-type,
undifferentiated mouse ES cells[22]. However, we consistently detect only three isoforms
in multiple, independently-derived embryonic stem cell lines (Figure 4.2).  To confirm
the identity of the three isoforms observed in our undifferentiated ES cells, we compared
the isoforms present in those cells to the isoforms present in HeLa cells and in mammary
tumor tissue from mouse Wap-T121 mammary tumors.  Previous work has demonstrated
that EED-1, EED-3, and EED-4 are expressed in HeLa cells and that EED-2 is
upregulated in many mouse tumors[22].  Consistent with those reports, we observed high
levels of EED-1, EED-3 and EED-4 and much lower levels of EED-2 in HeLa cells
(Figure 4.2A).  Similarly, EED-2, along with EED-3 and EED-4, was observed in Wap-
T121 mammary tumors (Figure 4.2B).  Comparison of the isoforms present in those
sources with the isoforms present in our embryonic stem cells confirmed the identity of
the isoforms we observe in embryonic stem cells as EED-1, EED-3, and EED-4 (Figure
4.2).
Deletion mapping of EED isoform start sites
Previous work has suggested that the four EED isoforms are generated by
utilizing four distinct translation initiation sites in a common Eed messenger RNA[13].
In the mouse, those putative start sites correspond to GUG 169-171, GUG 274-276, AUG
451-453, and AUG 493-495, respectively (Figure 4.3A).  Overall, mouse and human
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EED are very similar proteins.  In fact, the predicted EED-3 and EED-4 isoforms are
100% identical between the two species (37).  However, the sequences between the
putative EED-1 and EED-2 start sites, are much more variable [40]. Given the abrupt
boundary between highly variable and nearly identical sequences, we questioned whether
the actual EED-1 start site might be further 3’ than previously reported.
To map EED isoform start sites, we generated a series of Eed expression
constructs progressively truncated at the 5’ end of the Eed cDNA (Figure 4.3A).
Individual constructs were then transiently transfected into Eed mutant ES cells, which
lack detectable endogenous EED, and EED isoform expression was assessed by western
blotting.  In these experiments, the furthest 5’ intact translational start site was generally
utilized preferentially to downstream translational start sites (Figure 4.3).  This
observation suggests that regulated usage of the various EED translational start sites is
not simply a consequence of the interaction between trans-acting factors and sequences
present in the message but instead may be influenced by upstream events, such as
splicing.  Additionally, because isoform expression could be lost either by deleting past
an isoform start site or by deleting an upstream regulatory element required for
translation from an intact start site, the absence of a band is uninformative in this assay.
However, the continued presence of an isoform after its putative start site has been
deleted is strong evidence that the actual start site must be further downstream.
Consistent with the relaxed sequence conservation between mouse and human
Eed sequences beginning with and immediately downstream from GUG 169-171, EED-1
was expressed from constructs truncated 32 (Δ201) and even 88 (Δ257) nucleotides
beyond the reported EED-1 start site, suggesting that EED-1 may not initiate translation
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at GUG 169-171 as previously proposed (Figure 4.3B).  EED-1 expression was lost only
after deleting the 5’ 312 nucleotides of the Eed cDNA, a deletion extending 143
nucleotides beyond the reported EED-1 start site and 38 nucleotides beyond the published
EED-2 start site (Figure 4.3B).  Consistent with the published identity of the EED-3 start
site at AUG 451-453, this isoform was observed after deleting the 5’ 417 nucleotides but
not after deleting the 5’ 455 nucleotides (Figure 4.3B).  Finally, EED-4 was present even
in the largest truncation, which deleted the 5’ 455 nucleotides, consistent with the
published EED-4 start site residing at AUG493-495 (Figure 4.3B).
Confirmation of EED isoform start sites
To verify that GUG 169-171 is upstream of the actual EED-1 start site, we forced
expression from this codon by replacing the sequences encoding GUG 169-171 with a
canonical translation start site consisting of a consensus Kozak sequence followed by an
AUG initiator codon (Figure 4.4A).  Consistent with the hypothesis that EED-1
translation actually initiates further downstream, the resulting product was substantially
larger than EED-1 (Figure 4.4B, asterisk).  A lower level of an EED-1 sized product,
presumably initiating at the actual start site further downstream, was also observed after
transfection with this construct (Figure 4.4B, arrow).
Given that the deletion mapping data indicates that either the true EED-1 start site
or some regulatory element required for translation from the true EED-1 start site maps
between nucleotides 257 and 312, we hypothesized that EED-1 may be produced by
translation initiating from the predicted EED-2 start site at GUG 274-276.  To test that
possibility, we forced expression of a protein initiating translation at that site by replacing
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GUG 274-276 with a consensus Kozak followed by an AUG initiator codon (Figure
4.4A).  Consistent with EED-1 translation initiating at this location, the resulting product
was the same size as EED-1 observed in mouse ES cells (Figure 4.4B).
Because EED-2 was not expressed in our wild-type ES cells or from any of our
truncated expression constructs, we were unable to characterize this isoform.  However,
driving translation from a candidate start site at GUG 397-399 produced a protein that
appears to be smaller than EED-2 (data now shown), suggesting that the EED-2 start site
lies between GUG 274-276 and GUG 397-399 or that EED-2 is generated by alternative
mechanisms.
Our deletion mapping data were consistent with the presumptive EED-3 and
EED-4 start sites residing at AUG 451-453 and AUG 493-495, respectively.  To confirm
that translation of those isoforms originates at those sites, we engineered AUG→AUA
site directed point mutations into the AUG 451-453 and AUG 493-495 codons (Figure
4.4A).  Consistent with those codons being the initiation codons for the two smaller
isoforms, constructs harboring those mutations failed to express EED-3 and EED-4
(Figure 4.4C).
Ability of EED isoforms to mediate H3K27 methyltransferase activity
To determine whether all three EED isoforms present in our ES cells are required
to mediate the three H3K27 methylation states, Eed mutant ES cells were transiently
transfected with a series of Eed cDNA expression constructs.  This rescue assay has
previously been utilized to demonstrate that protein(s) expressed from a full-length Eed
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cDNA cassette can mediate all three H3K27 methylation states[32], although the role of
individual isoforms in that rescue has not been directly assessed.
Constructs harboring site-directed mutations to eliminate EED-3 and EED-4
expression or truncated to eliminate EED-1 expression were both able to rescue all three
H3K27 methylation states in Eed mutant ES cells (Figure 4.5D and E).  Additionally, a
construct retaining only the EED-4 start site also rescued H3K27me1, H3K27me2, and
H3K27me3 (Figure 4.5F).  As previously reported, expression of the Eedl7Rn5-3354SB allele,
which produces an unstable and nonfunctional protein harboring a L→P substitution,
failed to rescue H3K27 methylation(data not shown and [32]).  Collectively, these results
demonstrate that the three H3K27 methylation states are not dependent on individual
EED isoforms.
Disruption of EED WD-40 motifs eliminates methyltransferase activity
EED and its homologs in other organisms are WD-repeat proteins.  However,
there is disagreement about the number of WD-40 motifs present in EED, with estimates
varying between five and seven [41-43].  In functional studies assessing EED’s ability to
bind EZH2 or its ability to mediate transcriptional repression when tethered to a GAL4
DNA binding domain, only five WD-40 motifs have appeared functionally necessary [44,
45].  Those five motifs map to Eed cDNA sequences 721-808 (WD-40 motif 1), 1012-
1105 (WD-40 motif 2), 1150-1240 (WD-40 motif 3), 1330-1444 (WD-40 motif 4), and
1672-1762 (WD-40 motif 5).  To determine whether those same regions are required for
EED’s ability to mediate H3K27 methylation, Eed mutant ES cells were transiently
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transfected with a series of Eed cDNA expression constructs progressively truncated
from either the N- or C-terminus.
Deletion of any of the five putative WD-40 motifs abolished EED’s ability to
mediate H3K27 methylation, as demonstrated by immunofluorescence (Figure 4.6D-G).
However, N-terminally truncated proteins containing all five WD-40 motifs retained
H3K27 methyltransferase activity.  A protein lacking the N-terminal 16 amino acids of
EED-4 (Δ5’ 541) was able to mediate all three H3K27 methylation states (Figure 4.6B),
suggesting that the N-terminal regions in EED, including those amino acids that
distinguish individual isoforms, are not required for the catalytic activity of the PRC2
complex.  A second deletion, Δ5’ 697 also left the five putative WD-40 motifs intact.
However, protein expressed from this construct retains only 8 amino acids upstream of
WD-40 motif 1.  Although the expression of the Δ5’ 697 construct consistently rescued
the H3K27me1 defect, little if any H3K27me2 and H3K27me3 were observed (Figure
4.6C).
Nematode and fly Eed homologs fail to rescue H3K27 methylation defects in Eed
mutant cells
Given that EED’s WD repeats alone appear sufficient to mediate the PRC2
complex’s H3K27 methyltransferase activity, we examined whether the complex’s
requirement for a WD-repeat protein can be satisfied by WD-repeat proteins other than
EED, in particular Eed homologs from other organisms.  To address this question, Eed
mutant ES cells were transiently transfected with constructs expressing either the C.
elegans homolog of Eed, mes-6, or the D. melanogaster Eed homologs, esc and escl.
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Previous work has suggested that fly and mouse Eed homologs may not be functionally
equivalent, as Eed functions in a dominant negative fashion in flies.  Consistent with
functional differences in these homologous proteins, mes-6, esc, and escl were all unable
to rescue the H3K27 methylation defects in Eed mutant mouse ES cells (Figure 4.7), even
though MES-6 and ESC normally exist in PcG complexes with H3K27 methyltransferase
activity [10, 12, 46].
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4.5.  DISCUSSION
EED-1, EED-3, and EED-4 translation start sites map to GUG 274-276, AUG 451-
453, and AUG 493-495
Mammalian EED proteins are present as four isoforms of unclear function [13,
22, 23].  Previous work has suggested that the four EED isoforms are generated by
translation initiating at GUG 169-171, GUG 274-276, AUG 451-453, and AUG 493-495,
respectively [13, 14].  This interpretation followed from early studies by Denisenko and
Bomsztyk, who assessed EED proteins translated in a cell free system [14].
Subsequently, Kuzmichev et al. generated an isoform-restricted EED antibody, called
αNT, which was raised to peptides encoded by Eed cDNA sequences from positions 258-
453 (M26).  Because the αNT recognized EED-1 and EED-2 but not EED-3 and EED-4,
those results demonstrated that EED-1 and EED-2 must include the αNT epitope and
must initiate translation upstream of M451-453, as predicted by Denisenko and Bomsztyk
[14].
Here, we have directly assessed the identity of the EED translation start sites by a
combination approach involving deletion mapping, forced translation from reported start
sites, and site-directed mutagenesis of candidate initiation codons.  These experiments
definitively map EED-1, EED-3, and EED-4 start sites to GUG 274-276, AUG 451-453,
and AUG 493-495, respectively.  Importantly, because the informative αNT antibody
utilized by Kuzmichev et al. recognizes amino acids that would be present not only in a
hypothetical protein initiating at GUG 169-171 but also in a protein initiating at GUG
274-276, the EED-1 initiation site reported here, the immunoblotting data from
Kuzmichev et al. are fully consistent with the results presented in the present work [13].
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On other hand, these results do contradict the earlier work of Denisenko and Bomsztyk
[14].  Denisenko and Bomsztyk assessed EED proteins expressed from truncated and
engineered Eed cDNAs comparable to those utilized here.  However, whereas we
assessed translation from those messages in living cells, Denisenko and Bomsztyk
utilized a rabbit reticulocyte cell-free system.  In their assay, a truncation that would have
deleted the 5’ 222 nucleotides in our constructs eliminated EED-1 expression, even
though a truncation extending 35 nucleotides further (Δ257) did not disrupt EED-1
expression in our assay (Figure 4.3B).  The differences in our respective methodologies
may account for the discrepancy in our results.  The major advantage to the transient
transfection assay employed in this report is that it allows direct comparison of EED
expressed from expression constructs to endogenous EED expressed in the same cell
type.
In their cell-free system, Denisenko and Bomsztyk observed apparent
upregulation of EED-1 after mutating GUG 169-171 and flanking sequences to more
closely resemble a canonical initiation sequence.  Whereas a similar experiment in our
assays produced a protein larger than EED-1 (Figure 4.4B), Denisenko and Bomsztyk
reported production of an EED-1 sized protein.  A protein initiating at GUG 169-171 is
predicted to be less than 4 kDa larger than a protein initiating at GUG 274-276.  In our
hands, resolving these bands required large gels run at low voltage.  Accordingly,
differences in electrophoresis conditions could explain why the protein expressed in their
assay appeared to approximate the size of EED-1.
The absence of EED-2 expression precludes its characterization
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We were unable to characterize the EED-2 start site because endogenous
expression of that isoform was not detectable in our ES cells nor was EED-2 expression
detected from any truncated Eed expression construct expressed in ES cells.  Previous
studies demonstrated EED-2 expression in undifferentiated ES cells and in tumors [22].
It is not clear why EED-2 was not present in the ES cells utilized here.  Kuzmichev et al.
demonstrated that EED-2 is rapidly downregulated when ES cells are stimulated to
differentiate [22].  Hence, the most parsimonious explanation for our failure to detect
EED-2 is that the ES cells employed were beginning to differentiate when they were
harvested.  If so, the cells must nevertheless retain their full developmental potential,
because similarly cultured cells have contributed to all three germ layers in our hands in
embryonic chimera experiments [33].  In the event that the cells are beginning to
differentiate, one possible explanation would be the removal of the cells from fibroblast
feeders prior to harvesting in order to minimize feeder contamination in our
immunoblotting assays.  However, EED-2 was also not detectable in E14 ES cells
(Figure 4.2), which are feeder-independent [34].  Finally, because EED-2 was observed
in both mouse mammary tumors and in HeLa cells (Figure 4.2), the absence of EED-2 in
our ES cells is not simply a more general inability to detect EED-2.
Regardless of the reason that EED-2 was not expressed in our ES cells, its
absence precluded characterization of its start site.  However, a GUG at position 397-399
fulfills the minimal requirements of a translational start site [15, 16].  As a result, we
forced expression of a protein initiating at that location and compared it to EED-2 from
Wap-T121 mammary tumor tissue (data not shown).  The observed protein was smaller
than EED-2, implying that EED-2 translation must initiate upstream of GUG 397-399 but
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downstream of EED-1’s start site at GUG 277-279.  However, because we have not
observed EED-2 from an intact Eed mRNA, we cannot rule out that EED-2 could be
generated by a post-translational modification, such as cleaving, or by alternative
splicing.
EED isoforms do not regulate the number of methyl groups added to H3K27
Although the biological functions of H3K27me1 and H3K27me2 have not been
defined, it is clear from localization studies that the three H3K27 methylation states are
partitioned to nucleosomes associated with distinct regions of the genome (Figure 4.1 and
[24]).  This specificity, in turn, implies that the number of methyl groups added to a
particular nucleosome is a regulated process.  We hypothesized that EED isoforms could
function as regulatory switches controlling H3K27 methylation states.  However, none of
the EED isoforms were specifically required in order to generate H3K27me1,
H3K27me2, or H3K27me3 (Figure 4.5).  In fact, a truncated EED protein initiating
sixteen amino acids downstream of EED-4’s start site appeared to mediate H3K27
methylation as robustly as the full-length protein (Figure 4.6). These results demonstrate
that the N-terminal extensions discriminating EED isoforms are not required for the
enzymatic activity of the PRC2 complex.  Instead, we propose that the four isoforms
direct PRC2 complexes to distinct targets.  While such a regulatory function could
involve determining the protein substrates preferred by EZH2 as suggested by
Kuzmichev et al. [13], an equally intriguing possibility is that the isoforms function to
localize EED-containing complexes to distinct regions of the genome.
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EED WD-40 motifs and histone binding regions are required for H3K27
methylation
EED’s ability to mediate H3K27 methylation was lost in constructs truncated to
eliminate any of the protein’s five WD-40 motifs (Figure 4.6).  These observations are
consistent with earlier studies indicating that all five WD-40 motifs are required for
EZH2 binding and EED-mediated transcriptional repression [44, 45].  Interestingly,
whereas the Δ5’ 541 construct was able to rescue all three H3K27 methylation states, the
protein expressed from the Δ5’ 697 construct, which also retained all five WD-40 motifs,
was only able to mediate substantial levels of H3K27me1 (Figure 4.6B and 4.6C).
Recent work suggests that the N-termini of EED and of its fly homolog ESC bind to
histone H3 and that the histone binding N-terminus of ESC is required for H3K27me3
[47].  The Δ5’ 697 construct deletes the region of EED required for histone H3 binding.
Accordingly, the reduced levels of H3K27me2 and H3K27me3 mediated by this
construct suggest that, as in Drosophila, the histone H3-binding N-terminus of EED may
be required for full activity of PRC2 complex. Previously, we have demonstrated a
quantitative relationship between levels of EED and H3K27 methylation [32].  Whereas
low levels of EED are sufficient to mediate H3K27me1, higher levels appear necessary to
mediate H3K27me2 and H3K27me3.  The Δ5’ 697 protein is likely a severely impaired
protein that retains its ability to interact with the catalytic subunit via the intact WD-40
motifs but has greatly reduced activity due to the absence of the histone-binding N-
terminus.  As previously proposed, the histone-binding region of EED may be required to
position PRC2 complexes appropriately in order to mediate the necessary histone-
complex interactions required for full methylation [47]. Consequently, the Δ5’ 697
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protein appears to have an intermediate level of activity sufficient to mediate low levels
of H3K27 methylation but insufficient for full H3K27me3.
Fly and worm Eed homologs fail to rescue Eed mutant H3K27 methylation defects
Despite the presence of conserved functional motifs, including WD-40 motifs and
a histone binding amino terminus, the fly and worm homologs of Eed were unable to
rescue the H3K27 methylation defects in Eed mutant ES cells (Figure 4.7).  These results
extend earlier work indicating that EED and ESC and are not functionally equivalent.  In
Drosophila, Eed is unable to rescue esc mutant embryonic lethality and instead functions
in a dominant negative fashion, enhancing a leg transformation defect [48].  More
importantly, in vitro binding experiments fail to detect an interaction between mouse
EED and fly E(Z) [48].  Mouse EED and fly ESC are 55% identical and 74% similar in
the regions of the respective proteins harboring the WD-40 motifs that mediate
interaction with EZH2 and E(Z) [48].  Hence, these results suggest that subtle sequence
features that distinguish these proteins must be critical for functional interactions between
EED and EZH2 and between ESC and E(Z).
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FIGURE 4.1.  Localization of Histone H3K27 methylation marks
Immunofluorescence analysis of (A) H3K27me1, (B) H3K27me2, (C) H3K27me3, and
(D) HP1-α in CD1 murine embryonic fibroblasts.
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FIGURE 4.2.  Confirmation of EED isoform identities
Western blot analysis of EED comparing isoforms observed in wild-type or Eed mutant
embryonic stem cells to isoforms observed in (A) HeLa cells or (B) Mouse Wap-T121
mammary tumors.  On prolonged exposure, EED-2 becomes visible in HeLa lysates (A-
right panel).  EED isoforms 1-4 are indicated as 1, 2, 3, and 4.
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FIGURE 4.3.  Deletion mapping of EED translational start sites
(A) Constructs transfected into Eed mutant embryonic stem cell line 21 (below) are
shown.  Putative translation start sites for EED-1 (GUG 169-171), EED-2 (GUG 274-
276), EED-3 (AUG 451-453), and EED-4 (AUG 493-495) are indicated in the schematic
of the endogenous mRNA as 1,2,3, and 4 and correspond to codon locations in the mouse
Eed transcript (Accession number: BC012966).  Deletion numbers refer to nucleotides
removed from the 5’ end of the Eed cDNA (e.g. Δ210 refers to a construct expressing an
Eed cDNA lacking the 5’ 210 nucleotides of the full length message). (B)  Whole-cell
lysates from Eed+/+ ES cell line 25.5 (Wild-type), Eed-/- ES cell line 21 (Mutant), or Eed-/-
ES cell line 21 transiently transfected with the Eed expression constructs shown in
(A)were analyzed by Western blotting with an antibody detecting EED.
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FIGURE 4.4.  Verification of EED isoform start sites.
(A)  Constructs transfected into Eed mutant embryonic stem cell line 21.  1,2,3, and 4
indicate reported EED translational start sites GUG 169-171, GUG 274-276, AUG 451-
453, and AUG 493-495, respectively.  Black boxes refer to strong Kozak-AUG
sequences engineered into the expression construct in order to drive translation from the
169-171 codon (Kozak AUG 169-171) and from the 274-276 codon (Kozak AUG 274-
276), respectively.  “X” markings through the putative EED-3 and EED-4 start sites in
Δ417 no3,4 and in Δ455 no4  indicate AUG→AUA mutations intended to disrupt
translation intitation.  (B and C)  Whole-cell lysates from Eed+/+ ES cell line 25.5 (Wild-
type), Eed-/- ES cell line 21 (Mutant), or Eed-/- ES cell line 21 transiently transfected with
the Eed expression constructs shown in (A) analyzed by Western blotting with an
antibody detecting EED.
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FIGURE 4.5.  Histone H3K27 methylation in cells lacking one or more EED
isoforms
Immunofluorescence analysis of H3K27me1, H3K27me2, and H3K27me3 in wild-type
ES cell line 25.5 (Eed+/+) and in Eed mutant ES cell line 21 either mock transfected (Eed -
/-) or transiently transfected with the indicated constructs.  Eed expression constructs
transfected into ES cell line 21 are shown on the left.  Isoform start sites at GUG 274-
276, AUG 451-453, and AUG 493-495 are shown as 1*, 3, 4, respectively.  1*
discriminates the GUG 274-276 start site for EED-1 reported here from the GUG169-171
start site reported previously(7, 18).  DAPI-stained DNA is blue, and methylated histones
are shown in red.  “X” markings through the putative EED-3 and EED-4 starts sites in
Full length no 3,4 and in Δ417 no3,4 represent AUG→AUA mutations intended to
disrupt translation intitiation.  EED 1036-1038 L→P refers to Eedl7Rn5-3354SB, a point
mutant protein previously demonstrated to lack H3K27 methyltransferase activity. In the
transient transfection assay, approximately 10% of the ES cells are successfully
transfected, and with constructs expressing functional EED, a similar percentage of cells
are rescued.
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FIGURE 4.6.  Functional mapping of required WD-40 motifs in EED
Immunofluorescence analysis of H3K27me3 in Eed mutant ES cell line 21 either mock
transfected (Eed-/-) or transiently transfected with the indicated constructs. DAPI-stained
DNA is blue, and methylated histone are shown in red.  Diagonally-lined boxes refer to
putative WD-40 motifs encoded by cDNA sequences 721-808 (WD-40 motif 1), 1012-
1105 (WD-40 motif 2), 1150-1240 (WD-40 motif 3), 1330-1444 (WD-40 motif 4), and
1672-1762 (WD-40 motif 5) (38).  Black boxes refer to consensus Kozak + ATG initiator
sequences engineered into the construct.
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FIGURE 4.7.  Interspecies rescue analysis
Immunofluorescence analysis of H3K27me3 in Eed mutant ES cell line 21 transiently
transfected with constructs expressing the (A) mouse, (B) C. elegans or (C and D) D.
melanogaster Eed homologs.
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CHAPTER 5
SUMMARY AND FUTURE DIRECTIONS
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In recent decades, genetic and biochemical data in a variety of systems have
begun to clarify the role of PcG proteins in transcriptional memory.  However, critical
details of PcG-mediated silencing remain elusive.  Three particularly important questions
are 1)  how are PcG proteins recruited to their targets, 2)  how do PcG-mediated histone
modifications interplay with other epigenetic marks, and 3)  how are PcG-mediated
histone modifications regulated.  The data presented here begin to address all of these
questions.  Of equal importance, these data also define critical future experimental
directions that may further clarify the mechanistic details of PcG-mediated silencing. 
These issues are considered in detail below.
 
5.1.  RECRUITMENT OF POLYCOMB GROUP PROTEINS
In flies, PcG proteins are often recruited by sequence-specific transcription factors
to Polycomb Response Elements, which contain multiple copies of binding sites for a
number of Drosophila transcription factors, including Pleiohomeotic and GAGA Factor
[1].    However, similar elements have not been identified in mammals.  More recent
work suggests that fly PcG proteins can also be targeted by small RNAs [2].  Data
presented here and elsewhere demonstrate that Eednull/null cells and embryos have defects
in both X-chromosome inactivation and in KvDMR cluster imprinting (Figure 2.1-2) [3-
5].  Notably, both of these processes are dependent on noncoding RNAs.  These RNAs,
Xist and Kcnq1ot1, have been proposed to recruit trans-acting factors in cis to silence
genes on the Xi and in the KvDMR cluster, respectively[6-9].  Together, these
results suggest that mammalian PcG proteins could be recruited to the Xi, to the KvDMR
cluster, and perhaps to many other targets by noncoding RNAs like Xist and Kcnq1ot1. 
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Although this model is appealing, PcG proteins have not yet been demonstrated to
associate directly with Xist or Kcnq1ot1, and future studies must determine whether these
RNAs directly recruit PRC2 or whether they recruit intermediate molecules that
subsequently recruit PcG proteins.  This putative association could be assessed by
electrophoretic mobility shift assays with Xist or Kcnq1ot1 RNAs incubated with isolated
PRC2 complexes.
5.2.  INTERPLAY BETWEEN PcG-MEDIATED HISTONE MODIFICATIONS
AND OTHER EPIGENETIC MARKS
Diverse mechanisms are employed to modify and remodel the chromatin template
in order to influence gene expression.  In addition to the vast array of covalent
modifications found on histone tails, nucleosomes are also modified by the presence of
histone variants and physically displaced by ATP-dependent remodeling complexes [10,
11].  In some species, including mammals, an additional layer of epigenetic control is
provided by DNA methylation.  Accordingly, the cell has a diverse repertoire of
regulatory mechanisms at its disposal.
In many systems, stable gene expression states are produced by hierarchical
recruitment of several of these epigenetic regulators.  For instance, in a variety of
systems, transcriptional silencing is achieved by the coordinated action of HMTases and
DNA methyltransferases, often with, H3K9 methylation serving as an epigenetic mark
that directly or indireclty recruits DNA methyltransferases [12-14].
In contrast, the relationship between H3K27 methylation and DNA methylation is
less clear.  In at least one tumor cell line, DNMT1 directly associates with PRC2, and
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PRC2 is required for DNA methylation at several PcG-target genes in those cells [15].
Conversely, our own previous work has demonstrated that parent-of-origin DNA
methylation is maintained at several DMRs in Eednull/null embryos, including two DMRs
in the KvDMR cluster[4].  Given that EZH2 is lost in Eednull/null cells (Figure 3.2), these
results suggest that parent-of-origin DNA methylation, unlike imprinted expression at
these same loci, is not dependent on PRC2.  Hence, unlike the tumor cell data, these
results imply that PcG-mediated histone modifications and DNA methylation may be
targeted independently.
The data presented here support that interpretation.  If the functions of PcG
proteins and DNA methyltransferases are interdependent, one would expect mutations in
PcG genes and in DNA methylransferases to influence overlapping target genes.  Here,
we have demonstrated that Eednull/null TS cells have imprinting defects reciprocal to those
observed in Dnmt1null/null placentas (Figure 2.7) [9].  Specifically, the three proximal
genes in the KvDMR cluster that become biallelically expressed in Eednull/null TS cells are
imprinted normally in Dnmt1null/null placentas; conversely, the central and distal genes
misexpressed in Dnmt1null/null placentas are imprinted normally in Eednull/null TS cells.
These results suggest that maintenance DNA methylation and PcG-mediated histone
modifications have distinct targets and function independently in the KvDMR cluster.
However, these conclusions are tempered by an important caveat.  Although TS cells do
represent a primitive placental precursor, we have not assessed imprinting defects in
matched tissues from Eed and Dnmt1 mutants.  Accordingly, these conclusions may be
strengthened considerably by future work comparing KvDMR cluster imprinting in
Eednull/null and Dnmt1null/null TS cells.
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Even in the absence of a direct comparison between Eed and Dnmt1 mutant cells,
the tissue-specficity of epigenetic defects in Eed mutants is notable.  X-chromosome
inactivation defects in Eednull/null conceptuses are restricted to a population of
differentiating extraembryonic cells [5].  Similarly, I observed broader imprinting defects
in Eednull/null TS cells than in Eednull/null conceptuses, suggesting that defects in autosomal
imprinting in Eed mutants may also be restricted to, or at least more severe in,
extraembryonic cells.  In the mouse, extraembryonic tissues are DNA hypomethylated
relative to embryonic tissues, because embryonic tissues, unlike extraembryonic tissues,
are remethylated after implantation [16].  Eed may be dispensable at many loci in
embryonic tissues, because DNA methylation provides a robust, alternative epigenetic
memory system.  According to this model, in the absence of that reinforcement in
extraembryonic tissues, mutations in Eed have more dire consequences.  This
interpretation is supported by the ability to rescue Eedhypo/null midgestation lethality with
wild-type extraembryonic tissues, and it supports the view that DNA methylation and
PcG-mediated histone modifications function independently at many targets in the mouse
[17].
5.3.  REGULATED ADDITION OF METHYL GROUPS TO HISTONE H3K27
Histones can be mono-, di-, or trimethylated at several lysine residues, including
at H3K27.  However, in most cases, it is unclear what regulates how many methyl groups
are added to histones associated with a particular region of the genome.  Two simple
models have been proposed to control this specificity [18].  In the first model, distinct
mono-, di-, and trimethylating enzymes are responsible for each methyl state.  In the
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second model, a single enzyme mediates all three methyl states but is regulated so as to
add one methyl group to certain nucleosomes and two or three to others.  Regulation of
the enzyme could be mediated by the presence of regulatory subunits, post-translational
modifications, etc.
Here, we have demonstrated that the PcG gene Eed is required for all three
H3K27 methylation states in our high passage ES and TS cells (Figure 3.1 and
Supplementary Figure 3.1).  Eednull/null cells have dramatically reduced levels of EZH2,
the catalytic subunit of the PRC2 complex, suggesting that EZH2 is unstable outside of
intact PRC2 complexes (Figure 3.2).  Additionally, we have demonstrated that transient
transfection of an Eed cDNA expression cassette rescues the H3K27 methylation defects
in Eednull/null cells, confirming that EED can mediate H3K27me1, H3K27me2, and
H3K27me3 (Figure 3.4 and Supplementary Figures 3.2 and 3.3).
Alone, these results appear to support the second model, in which a single
complex mediates all three methyl states.  However, unlike Eed mutants, embryos and
cells homozygous for a gene trap mutation in the PRC2 subunit Suz12 retain H3K27me1
[19].  Suz12 mutants have been reported to lack EZH2, while retaining EED.  These
results imply that SUZ12 and EZH2, unlike EED, are dispensable for H3K27me1.
Supporting this conclusion, Eednull/null cells stably expressing a low level of EED have
robust H3K27me1, even in the absence of an observable rescue of EZH2 protein levels
(Figures 3.3 and 3.4).
We have interpreted these results to suggest that EED mediates monomethylation
independently of SUZ12 and EZH2 (Chapter 3).  However, there are alternative
interpretations to explain the presence of H3K27me1 in both Suz12 gene trap mutants and
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in Eednull/null  cells stably expressing Eed.  Although Suz12 gene trap mutants appear to be
null mutants as assessed both by embryonic phenotype (which is comparable to the
Eednull/null mutant phenotype) and by the apparent absence of residual SUZ12 protein,
gene traps do not provide a “clean” genetic lesion.  That is to say, gene traps terminate
transcription by providing a strong splice acceptor sequence upstream of a transcriptional
termination sequence.  The splice acceptor allows the cassette to “trap” spliced transcripts
in order to produce truncated and often unstable proteins.  As a result, gene traps will
produce a true null mutation only if all transcripts splice into the trap.  On the other hand,
if a percentage of transcripts splice around the trap, wild-type message and wild-type
protein will be produced.  As a consequence, proving that a gene trap is a null allele is
dependent on the detection limits of molecular assays used to identify the untrapped
mRNA or protein.  Hence, it is formally possible that the Suz12 gene trap creates a severe
hypomorphic but not null allele.  For similar reasons, it is possible that a low level of
EZH2 persists in those mutants and in our Eednull/null  cells that stably express Eed.  As a
result, an alternative interpretation of our data is that H3K27me1 requires only a very low
level of PRC2, and that sufficient PRC2 persists in Suz12 gene trap mutants and in
Eednull/null  cells stably expressing Eed.  This possibility cannot be formally excluded until
cells harboring a deletion that removes the Ezh2 SET domain have been analyzed for
H3K27me1.
As an alternative, we proposed that PRC2 complexes containing distinct EED
isoforms could be responsible for H3K27me1, H3K27me2, and H3K27me3.  We have
demonstrated that EED-1, EED-3, and EED-4 are produced by translation initiating at the
positions GUG 277-279, AUG 452-454, and AUG 494-496 in the Eed mRNA,
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respectively (Figures 4.3 and 4.4).  However, these isoforms are not required for any of
the H3K27 methylation states (Figure 4.5).  Instead, a truncated form of EED containing
only the protein’s WD-40 and histone binding motifs is sufficient for all three marks
(Figure 4.6).  Hence, the mechanisms controlling the number of methyl groups added to
H3K27 remain elusive.  However, as an important starting point, we have identified the
first protein, EED, involved in mediating all three marks.
Determining the mechanisms regulating H3K27me1, H3K27me2, and H3K27me3
may prove to be a formidable task.  Because there are no known biological readouts of
H3K27me1 or H3K27me2, it would be difficult to design an effective screen for genes
required for these marks.  In simpler organisms with more comprehensive genetic tools,
such as S. cerevisiae, it would be possible to prepare histones from a library of mutants
with mutations in all known genes and then to directly assess the status of each methyl
state in each mutant by western blotting.  However, neither S. cerevisiae nor S. pombe,
have H3K27 methylation or orthologs of PcG proteins.
A related question is whether methyl groups are added sequentially to H3K27 or
whether unmethylated histones can be directly di- or trimethylated.  We have observed a
quantitative relationship between EED protein levels and H3K27 methylation (Chapter
3).  Additionally, in cells harboring a Suz12 mutation that may be hypomorphic for PRC2
function, the normally H3K27 trimethylated inactive X chromosome becomes
dimethylated (S. Chamberlain and T. Magnuson, submitted).  These results suggest that a
low level of PRC2 activity may be sufficient for lower H3K27 methylation states and that
higher levels may be required for full methylation.  If true, the mechanisms controlling
H3K27 methylation states may simply involve regulating the stability of PRC2
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association with chromatin.  Regions were PRC2 is only transiently associated with
histones may be monomethylated, whereas regions where PRC2 is stably tethered may be
di- or even trimethylated.  If true, this trend might be recapitulated by tethering PRC2 to
DNA binding transcription factors with weak or strong affinity for various templates.  A
variation on this model is that H3K27me1 could be added to histones prior to their
incorporation into chromatin and that di- and trimethylation are marks that are only added
to nucleosomal substrates.  This possibility could be assessed by analyzing H3K27
methylation in free histones associated with chromatin assembly complexes.
The functions of EED isoforms also remain unclear.  At a mechanistic level,
initial studies suggested that EED-3 and EED-4 direct EZH2 to methylate H3K27,
whereas EED-1 and EED-2 direct EZH2 towards histone H1K26[20].  However,
subsequent studies utilizing similar biochemical strategies failed to confirm these
findings[21].  Additionally, we have demonstrated that the EED-3 and EED-4 start sites
are dispensable for H3K27 methylation (Figure 4.5).  As a result, mechanistic distinctions
between the isoforms have not been clearly defined.
However, EED isoforms do appear to be developmentally regulated, and EED-2
is clearly upregulated in many tumors and may also be upregulated in stem cells[22].
This dynamic regulation suggests that EED isoforms are functionally significant.  One
intriguing possibility is that these isoforms are required to recruit PRC2 complexes to
distinct target genes.  However, identifying isoform-specific targets awaits the
availability of robust isoform-restricted antibodies or the generation of mice harboring
mutations that eliminate the expression of individual isoforms.
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5.4.  Conclusions
Although transcriptional silencing by PcG proteins has been co-opted to regulate
diverse targets in the course evolution, the molecular mechanisms responsible for this
silencing are remarkably conserved.  The data presented in this dissertation reflects both
the adaptability of PcG-silencing and the conservation of the molecular mechanisms
responsible for that silencing.  We have demonstrated a specific role for the mouse PcG
gene Eed in genomic imprinting, but we also have uncovered what is likely to be a more
general requirement for Eed and its homologs in histone methylation.  Together, these
results extend our understanding of the evolutionarily diverse roles for PcG silencing as
well as the evolutionary conserved mechanisms of PRC2 function.
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APPENDIX
PERINATAL LETHALITY OF C57BL/6.CD1 (N4-N6F1) EEDHYPO/HYPO MICE
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6.1. INTRODUCTION
As mentioned in previous chapters, two ENU-generated Eed alleles, Eednull and
Eedhypo, have been utilized to characterize PRC2 function in vivo. Transient transfection
of constructs expressing Eedhypo rescues the H3K27 methylation defects in Eednull/null cell
lines, and H3K27me1, H3K27me2, and H3K27me3 are all present in Eedhypo/hypo
fibroblasts (Figure 3.3, Supplementary Figures 3.2 and 3.3, and data not shown).  These
results indicate that unlike Eednull, Eedhypo retains the ability to mediate PRC2 function, at
least at a low level.  Instead, the phenotypes in Eedhypo/hypo animals are likely a
consequence of the reduced stability of the EEDhypo protein (Figure 3.4).
Eedhypo/hypo animals are generally viable but runted on outbred backgrounds, with
skeletal transformations due to abnormal homeotic gene expression boundaries[1-3].  The
animals also appear to be subfertile, although a detailed analysis of Eedhypo/hypo fertility has
not been performed.  Many mutations in the mouse produce strain-dependent phenotypes,
which are a consequence of genetic interactions between that mutation and one or more
variants present at other loci[4, 5].  Eedhypo/hypo animals have been characterized
predominantly on an outbred CD1 background[3].
The Eedhypo allele is an T→A substitution that converts a nonpolar isoleucine in
the third of EED’s five WD-40 motifs into a polar asparagine[2].  This point mutation
does not create or eliminate any known restriction enzyme recognition sites, meaning that
one must utilize linked markers for genotyping.  Originally, the coat color gene
Tyrosinase (Tyr) was used as a linked, visible marker for maintenance of the Eedhypo
stock[3].  However, Tyr is nearly 3 Mb from Eed, and recombination events, though
infrequent, can complicate stock maintenance.  Following the publication of the mouse
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genome sequence, the increasing availability of strain single nucleotide polymorphism
(SNP) data facilitated the identification of an informative SNP 2.1 kb from the Eedhypo
mutation.  Because the Eed mutant alleles were originally generated on a Balb/c
background and because this SNP generates a restriction fragment length polymorphism
(RFLP) in which NlaIII cuts a C57BL/6 allele but not a Balb/c allele, it provides a useful
molecular marker for Eedhypo genotyping.  In the course of backcrossing the Eedhypo
mutation onto a C57BL/6 background for genotyping purposes, we observed highly
penetrant, perinatal lethality not previously reported in Eedhypo/hypo animals.
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6.2. METHODS AND MATERIALS
Strain maintenance and genotyping
A Balb/c – C57BL/6 NlaIII RFLP was identified in the Celera mouse genome
database.   This SNP resides 2.1 kb from the site of the Eedhypo mutation.
In the first generation, sequence-confirmed Eedhypo/+ animals were backcrossed to
C57BL/6 animals.  The genotypes of animals in new litters were determined as follows.
First, genomic DNA was prepared from ear tissue by treatment in ear lysis buffer (50 mM
Tris, pH 8.8;  1 mM EDTA;  0.5% Tween-20;  20 µg/mL proteinase K).  Lysates were
genotyped by PCR with primers flanking the polymorphism (Fwd:
CAGGCAGTCATTTCATCCGTTC,  Rev:  GGAGGAGGAGGAAGATTTCAACAC),
followed by digestion with NlaIII (New England Biolabs).  In subsequent backcrosses,
both Eedhypo/+ males and females were utilized to insure that both sex chromosomes were
also being crossed onto the C57BL/6 background.
For intercrosses, C57BL/6 backcross generation-matched Eedhypo/+ dams and sires
were mated, and cages were checked daily for new litters.  At birth, animals were first
visually genotyped by eye pigmentation (Eedhypo/hypo animals are typically albino because
Eed is tightly linked to Tyr, and the ENU-generated Eed alleles were generated in an
albino Balb/c stock).  At weaning, DNA was prepared from survivors for molecular
genotyping as described above.  Deviation from predicted Mendelian frequencies was
assessed by chi-square testing.
For embryological analyses, timed-matings were performed, and dams were
sacrificed at embryonic day 18.5 (E18.5).  Embryos were dissected from maternal tissue,
weighed, and genotyped by eye pigmentation.
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6.3.  RESULTS
As the Eedhypo allele was backcrossed onto a C57BL/6 background, regular
intercrosses were performed to generate Eedhypo/hypo animals.  Consistent with previous
reports, in outcrosses involving either the original, outbred stock or Eedhypo/+ animals
generated from one or two backcrosses to C57BL/6 (herein referred to C57BL/6.CD1
(N1), C57BL/6.CD1 (N2), etc.), Eedhypo/hypo animals were observed at predicted
frequencies at weaning (Table 6.1).  However, Eedhypo/hypo animals were almost never
observed at weaning in litters from intercrosses involving Eedhypo/+ C57BL/6.CD1 (N4-
N6) animals (Table 6.1).
In order to determine whether the preweaning lethality of Eedhypo/hypo
C57BL/6.CD1 (N4-N6F1) animals occurred before or after birth, intercross cages were
checked daily for new litters, and pups were genotyped at birth.  Eedhypo/hypo
C57BL/6.CD1 (N4-N6F1) animals and corpses were recovered at Mendelian frequencies
at postnatal day 1 (P1) (Table 6.2).  However, half of these animals were already dead,
and the remainder died by postnatal day 2 (P2).
In order to determine whether any Eedhypo/hypo embryos were dying prenatally,
timed Eedhypo/+ C57BL/6.CD1(N6) intercross matings were performed and litters were
collected at embryonic day 18.5 (E18.5). C57BL/6.CD1(N6F1) Eedhypo/hypo E18.5 embryos
were alive but runted (Table 6.3 and Figure 6.1).  On average, C57BL/6.CD1(N6F1)
Eedhypo/hypo embryos were 25% smaller than their wild-type littermates.
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6.5.  DISCUSSION
The cause of death in C57BL/6.CD1 (N4-N6F1) Eedhypo/hypo animals is unclear.
Perinatal lethality can be caused by a wide range of developmental defects, and
determining a primary cause of death in mutants dying at these stages can be difficult.
As a consequence, in the absence of physiological details, perinatal lethality is often
explained as a “failure to thrive.”  Although that description is mechanistically vague, it
may be appropriate in discussing C57BL/6.CD1 (N4-N6F1).  Eedhypo/hypo perinatal
lethality.
After four to six backcrosses, the Eedhypo mutation is expected to reside in a
background where, on average, 93.75%-98.4% of unlinked loci are C57BL/6.  The strain-
dependent lethality indicates that one or more C57BL/6 alleles are compromising the
fitness of Eedhypo/hypo animals.  While this genetic interaction could reveal gene products
important to Eed function, it is also possible that the strain-dependent lethality simply
reflects the reduced vigor of an inbred mouse strain.  In other words, C57BL/6.CD1 (N4-
N6F1) Eedhypo/hypo animals may essentially be “sick with two, unrelated diseases,” the first
caused by the Eed genotype and the second caused by being inbred.  Together, those two
independent but additive disadvantages may make it difficult for these animals to
compete with their siblings for their mother’s resources.  Supporting this conclusion,
E18.5 C57BL/6.CD1 (N6F1) Eedhypo/hypo E18.5 embryos are already runted, and these
smaller mutant animals are likely to be at a competitive disadvantage in the critical hours
immediately following parturition.  If true, C57BL/6.CD1 (N4-N6F1) Eedhypo/hypo lethality
might be rescued simply by separating mutants from their wild-type siblings and
providing them with a competent, outbred foster mother.
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The prenatal runting in C57BL/6.CD1 (N6F1) Eedhypo/hypo embryos is itself an
interesting phenotype. Eedhypo/hypo fibroblasts have proliferation defects (Y. Chen and T.
Magnuson, personal communication), suggesting that this runting could be due to a
developmental delay caused by slowed growth in mutant embryos.  The perigastrulation
arrest in Eednull/null embryos is partially rescued by a mutation in Cdkn1c, a cell cycle
inhibitor (J. Mager and T. Magnuson, personal communication).  If the prenatal runting
and perinatal lethality in C57BL/6.CD1 (N4-N6F1) Eedhypo/hypo embryos is due to reduced
rates of proliferation, mutations in cell cycle inhibitors may be able to rescue these
defects as well.
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C57BL/6 Backcrosses Eed+/+ Eedhypo/+ Eedhypo/hypo χ2 P value
0-2 7 (8.5) 19 (17) 8 (8.5) 0.53 0.767
4-6 13 (9.5) 24 (19) 1 (9.5) 10.21 0.006
TABLE 6.1. Strain-dependent lethality in Eedhypo/hypo animals
C57BL/6.CD1 (N0-N2) or C57BL/6 (N4-N6) Eedhypo/+ animals were intercrossed, and
progeny were molecularly genotyped at weaning.  Observed numbers of animals of
genotype are indicated with expected numbers shown in parentheses.  Deviation from
expected ratios was assessed by chi square analysis, assuming one degree of freedom.
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 Wild-type Eedhypo/hypo
P1 18 6*
P2 18 3**
TABLE 6.2.  Perinatal lethality of C57BL/6.CD1 (N4-N6F1) Eedhypo/hypo animals
C57BL/6.CD1 (N4-N6) Eedhypo/+ animals were intercrossed, and progeny were genotyped
at P1 or P2 by scoring eye pigmentation.  Because Eedhypo is tightly linked to a
nonfunctional Tyr allele, animals lacking eye pigmentation will generally be Eedhypo/hypo
and animals with pigmented eyes will be Eed+/+ or Eedhypo/+.
*  3 of 6 albino animals recovered at P1 were dead.
**  3 of 3 albino animals recovered at P2 were dead.
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 Wild-type Eedhypo/hypo
Mass (g) 1.30 ± 0.04 0.98 ± 0.13
TABLE 6.3. Prenatal runting in C57BL/6.CD1 (N6F1) Eedhypo/hypo embryo
Timed intercross matings were conducted between C57BL/6.CD1 (N4-N6) Eedhypo/+
animals, and litters were sacrificed at E18.5.  Embryos were weighed and then genotyped
by scoring eye pigmentation as explained above. Means and standard deviations are
shown.  The difference in mean mass between wild-type and mutant embryos is
statistically significant, as assessed by an unpaired t-test (P < 0.0001).
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FIGURE 6.1.  Prenatal runting in C57BL/6.CD1 (N6F1) Eedhypo/hypo embryos
C57BL/6.CD1 (N6F1) Eedhypo/hypo (left) and wild-type (right) E18.5 embryos from
C57BL/6.CD1 (N6) Eedhypo/+ intercrosses.  On average, mutants are 25% smaller than
their wild-type littermates (Table 6.3).
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